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ABSTRACT: Marine mussels secret protein-based adhesives,
which enable them to anchor to various surfaces in a saline,
intertidal zone. Mussel foot proteins (Mfps) contain a large
abundance of a unique, catecholic amino acid, Dopa, in their
protein sequences. Catechol offers robust and durable adhe-
sion to various substrate surfaces and contributes to the curing
of the adhesive plaques. In this article, we review the unique
features and the key functionalities of Mfps, catechol chemis-
try, and strategies for preparing catechol-functionalized poly-
mers. Specifically, we reviewed recent findings on the
contributions of various features of Mfps on interfacial binding,
which include coacervate formation, surface drying properties,
control of the oxidation state of catechol, among other fea-
tures. We also summarized recent developments in designing
advanced biomimetic materials including coacervate-forming
adhesives, mechanically improved nano- and micro-composite
adhesive hydrogels, as well as smart and self-healing materi-
als. Finally, we review the applications of catechol-
functionalized materials for the use as biomedical adhesives,
therapeutic applications, and antifouling coatings. VC 2016 The
Authors. Journal of Polymer Science Part A: Polymer Chemis-
try Published by Wiley Periodicals, Inc. J. Polym. Sci., Part A:
Polym. Chem. 2016, 00, 000–000
KEYWORDS: adhesives; adhesive polymers; biomaterials;
biomimetic design; biopolymers; Dopa; mussel foot proteins;
wet adhesion
INTRODUCTION Marine mussels have mastered the ability to
anchor to foreign surfaces in seawater through the use of adhe-
sive proteins.1 These mussel foot proteins (Mfps) are known to
cure rapidly to form adhesive plaques with high interfacial
binding strength, durability, and toughness. 3,4-Dihydroxyphe-
nylalanine (Dopa), which is modified from tyrosine through
post-transitional hydroxylation, is one of the main constituents
in Mfps.2–4 The catechol side chain of Dopa has the ability to
form various types of chemical interactions and crosslinking,
which imparts Mfps with the ability to solidify in situ and bind
tightly to various types of surface substrates. To harvest the
remarkable wet adhesive properties of these adhesive proteins,
many efforts have been made to develop new adhesive materi-
als inspired by the designs of Mfps.
Natural Mfps have been extracted and analyzed from differ-
ent species of mussels in the aim of creating strong adhesive
materials.5,6 However, several thousand mussel specimens
are required for extracting one gram of adhesive proteins,
making the direct use of these adhesives for commercial
applications highly challenging.7 This highlights the need for
developing synthetic mussel-inspired adhesive polymers
with strong water-resistant adhesive properties.
The adhesive mechanism of marine mussels and the key fea-
tures of Mfps that affect adhesive properties have been
extensively studied during past decades, which provide guid-
ance for developing new synthetic biomimetic adhesives.8–10
Here, we provide an updated review on the design of adhe-
sive materials inspired by Mfps. We first describe the unique
features of adhesive plaque proteins and their key function-
alities as well as strategies for preparing biomimetic adhe-
sive polymers. We also summarize the recent developments
in designing advanced mussel-inspired materials including
coacervated Dopa-functionalized adhesives, mechanically
improved nano- and micro-composite adhesive hydrogels,
hydrogel actuators, self-healing hydrogels, and smart adhe-
sives. Finally, the applications of these adhesive materials as
biomedical adhesives, drug carriers for therapeutic uses, and
antifouling coatings are reviewed.
CHEMISTRY OF ADHESION: MUSSEL ADHESIVE PROTEINS
Mussel adhesives proteins enable marine mussels to attach
strongly to various surfaces in their turbulent, wet and saline
habitats.1 These proteins are secreted in a liquid form, which
then solidify to form a byssal thread and an adhesive plaque
VC 2016 The Authors. Journal of Polymer Science Part A: Polymer Chemistry Published by Wiley Periodicals, Inc.
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complex (Fig. 1). The byssal threads are engineered to with-
stand elevated mechanical loads applied by waves and cur-
rents. A byssal thread connects a mussel to the adhesive
plaque that is anchored to a foreign surface.2,11 The average
force needed to dislodge a California mussel, Mytilus califor-
nianus, is estimated to be 250–300 N/mussel, with an average
detachment force of 5–6 N/thread.12,13 This remarkable sur-
face anchoring capacity provides insights in designing synthet-
ic polymers for interfacial applications. In this section, we
review the compositions and chemistries of various plaque
proteins with a specific focus on those found at the plaque-
surface interface that contribute to strong interfacial binding.
Mussel Foot Proteins
At least six Mfps (Mfp-1 through Mfp-6) have been identified
from the adhesive plaques of several species of mussel (i.e.,
Mytilus edulis, Mytilus galloprovincialis, M. californianus,
etc.).14 These proteins are characterized by a basic isoelectric
point (pI) due to a high content of cationic amino acids. The
pI is described as the pH in which the net charge of the pro-
tein is zero.15 Most importantly, these plaque proteins con-
tain various amounts of the unique amino acid, Dopa.3,4 The
catechol side chain of Dopa offers robust and durable adhe-
sion to various substrate surfaces and contributes to the cur-
ing of the adhesive plaques.4 Mfps extracted from different
Mytilus species exhibited a high level of sequence homology
and a similar distribution within the adhesive plaque
(Fig. 1).12,13 These findings suggest that each type of Mfp
has a unique function and contributes differently to the
interfacial properties of the adhesive plaque.
Mfp-1 is a high molecular weight (e.g., 108 kDa in M. edulis)
and basic protein with very little secondary structures.16 It
is located in the cuticle of the byssus threads and the adhe-
sive plaques and acts mainly as a protective varnish layer.17
Mfp-2 is a smaller protein (e.g., 42–47 kDa in M. edulis) with
highly repetitive motifs and is the most abundant protein
found within the plaque (25 wt %).18 Mfp-2 contains a rel-
atively high content of cysteine residues (6 mol %) in the
form of disulfide bonds, and it is believed that Mfp-2 pro-
vides structural integrity to the adhesive plaques.18 Mfp-4
consists of a histidine- (His-) rich decapeptide tandemly
repeated more than 36 times, which binds exceptionally well
to transition metal ions such as copper.19 Mfp-4 is strategi-
cally located between the adhesive plaque and the distal por-
tion of the byssal thread, effectively linking plaque proteins
(e.g., Mfp-2) with those found within the byssal thread (e.g.,
preCOL).9,19 PreCols are collagenous proteins with high Dopa
and His contents and these proteins are mainly distributed
throughout the byssal threads.20,21 Specifically, Mpf-4 is
believed to interact with the His-rich domain of preCOLs
through metal ion coupling.9,19,22
Mfp-3, 5, and 6 are predominantly found at the plaque–sub-
strate interface, contributing to strong, wet adhesion. Mfp-3
is the smallest adhesive protein among plaque proteins (e.g.,
molecular weight of 5–7 kDa in M. edulis and M. california-
nus).22–24 It is the most polymorphic adhesive protein with
no known repeating sequences.24 It is reported to have over
30–35 different variants, which can be further subdivided
into two separate groups known as Mfp-3 fast and slow
(Mfp-3f and Mfp-3s, respectively).24,25 Based on the sequen-
ces reported for M. californianus (Table 1), both Mfp-3f and
Mfp-3s are rich in glycine (25–29 mol %) and asparagine
(10–18 mol %).24 Additionally, Mfp-3f exhibits elevated con-
tents of post-translationally modified Dopa (> 20 mol %)
and 4-hydroxyarginine (1 mol %), and positively charged
residues (26 mol %) [Fig. 1(A,E)], which renders Mfp-3f
highly hydrophilic.
In contrast, Mfp-3s exhibits a lower conversion of tyrosine to
Dopa residues (5–10 mol %) and contains a lower charge
density (9 and 3 mol % positively and negatively charged
residues, respectively) when compared to Mfp-3f, resulting
in a polar but hydrophobic protein [Fig. 1(B)]. However, its
Dopa content can approach 28 mol % in some variants,
which may be crucial for adhesion to metal and mineral sur-
faces.24 This level of Dopa content is only exceeded by
another plaque protein, Mfp-5.26 In Mfp-3s, Dopa is
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protected from oxidation even in footprints left behind from
the removed plaques. This is surprising given the susceptibil-
ity of the Dopa to autoxidation at the pH of seawater (pH
7.5–8.4).27 We reviewed the possible reduction–oxidation
(redox) chemistry of plaque proteins in the subsequent sec-
tion entitled “Effect of Oxidation State of Catechol.”
Mfp-5 has a molecular mass of 8.9 kDa and is the least poly-
morphic plaque proteins, consisting of one protein sequence
with two closely related variants.14,26 Mfp-5 contains the
highest amount of the adhesive Dopa (30 mol %) residues
amongst all the plague proteins [Fig. 1(C)].14 Mfp-5 is also
characterized by its hydrophilicity and a basic pI due to an
FIGURE 1 Schematic representation of a byssal thread and adhesive plaque with the approximate distribution of known Mfps. Pri-
mary sequences of Mfp-3f (A), Mfp-3s (B), Mfp-5 (C), and Mfp-6 (D). Acidic, basic, Dopa, and aromatic residues are shaded blue,
red, dark purple, and light purple, respectively. Post-translational modification of tyrosine to Dopa and the formation of disulfide
cysteine could occur anywhere within the peptide sequences. Pie charts illustrating the distribution of key functionalities found in
selected Mfps (E).
JOURNAL OF
POLYMER SCIENCE WWW.POLYMERCHEMISTRY.ORG REVIEWS
WWW.MATERIALSVIEWS.COM JOURNAL OF POLYMER SCIENCE, PART A: POLYMER CHEMISTRY 2016, 00, 000–000 3
elevated content of cationic amino acids (27.7 mol %). Addi-
tionally, Mfp-5 also contains variable amounts of post-
translationally modified phosphoserine (4.8 mol %), known
for its ability to bind to calcareous mineral materials (e.g.,
statherin and osteopontin).28,29 The presence of elevated
Dopa content and phosphoserine suggest that Mfp-5 plays
an important role in interfacial binding.
Unlike aforementioned interfacial plaque proteins, Mfp-6
contains a much lower amount of Dopa (3 mol %) but a
higher levels of tyrosine (20 mol %) [Fig. 1(D)].14 Although
the total phenolic residues content in Mfp-6 is similar to
those found in Mfp-3 and 5, the tyrosine residues in Mfp-6
are not efficiently converted to Dopa. Additionally, Mfp-6 has
the highest contents of charged residues (23 and 16 mol %
anionic and cationic amino acids, respectively). Another
unique feature of Mfp-6 is the presence of cysteine (11 mol
%) with a small portion of these residues present in the
form of disulfide bonds (2 mol %). The high level of thiol
gives Mfp-6 the ability to effectively control the redox chem-
istry of Dopa residues present in other plaque proteins,14,30
which is further reviewed in a later section.
Catechol Chemistry
One of the unique features of Mfps is the abundance of the
catecholic amino acid, Dopa, in their protein sequences. The
presence of catechol is believed to fulfill the dual role of inter-
facial binding and the solidification of the adhesive proteins.31
Catechol is capable of diverse chemistries, which enables it to
bind to both organic and inorganic surfaces through the
formation of reversible non-covalent or irreversible covalent
interactions (Fig. 2). These chemical reactions are also critical
to designing in situ curable materials. In this section, we sum-
marize various catechol side chain chemical interactions.
Non-Covalent Dopa Interactions
The dihydroxy functionality of catechol enables it to form
strong hydrogen bonds [H-bonds, Fig. 2(A)], which promotes
its absorption to mucosal tissues32,33 and hydroxyapatite
surfaces.34,35 The benzene ring of catechol is capable of
interacting with other aromatic rings through p–p electron
interaction [Fig. 2(B)],1,11 which improves the cohesive prop-
erties of catechol-containing polymers and enables them to
attach to surfaces rich in aromatic compounds (e.g., polysty-
rene)36 and gold substrates.37 The aromatic ring also forms
cation–p interaction with positively charged ions, which is
one of the strongest non-covalent interactions in water [Fig.
2(C)].38–40 Cation–p interaction enhances absorption of cate-
chol to charged surfaces41 and contributes to the cohesive
properties of materials rich in both aromatic and cationic
functional groups.42 Since catechols are easily oxidized to its
poorly adhesive quinone form in an oxygen rich and basic
environment, cation–p interaction complements the under-
water adhesive properties of catechol.42–45
Catechol chelates metal ions to form strong, reversible com-
plexes with various metal ions, including Cu21, Zn21, Mn21,
Fe31, V31, Ti31, and Ti41 [Fig. 2(D)].46–49 The log stability con-
stants of these complexes are significantly higher when com-
pared to those of polymeric acid- or amino acid-based ligands
TABLE 1 Amino Acid Composition of Mussel Foot Proteins Isolated From the Plaque Represented in the Number of Residue Per
100 Residues
Amino acids Mfp-3f Mfp-3s Mfp-5 Mfp-6
Pro (P) 6.0 8.0 3.6 4.9
Gly (G) 25.0 29.0 19.6 13.7
Ala (A) 2.0 1.0 2.7 2.9
Cys (C) 0 0 0 2.9
Asp/Asn (D/N) 10.0 18.0 3.6 13.4
Glu (E) 1.0 1.0 0.6 2.3
Ser (S) 1.0 2.0 1.2 4.3
pSera 0 0 4.8 2.8
Dopa 19.0 8.0 30.4 3.2
Tyr (Y) 1.0 19.0 0.2 19.2
Trp (W) 6.0 – 0 0
His (H) 1.0 3.0 4.8 0
Lys (K) 15.0 4.0 19.8 9.8
hArgb 1.0 0 0 0
Arg (R) 9.0 2.0 3.1 6.5
Total 100 99 100 100
Reference 19 19 14 14
a Phosphoserine.
b Hydroxyarginine.
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(e.g., log stability constant of 62 for Ti41 in a tris-catecholate
complex).50,51 Catechol forms complexes with different stoichi-
ometry (i.e., mono-, bis-, and tris-catecholate–metal ion
complexes), depending on the valency of the metal ion, catechol
to metal ion molar ratios, and pH.46,52,53 Catecholate–metal ion
complexation increases the wear resistance of byssal thread
FIGURE 2 Possible interactions and reaction products of the catechol side chain of Dopa. Catechol forms hydrogen bonds through
its AOH groups (A), p–p electron interaction with another benzene ring (B) and, cation–p interaction with positively charged ions
(C). Catechol chelates metal ions to form self-healing crosslinking (D) and, forms co-ordination bonds with metal oxide surfaces
(E). Dopa oxidizes to its semiquinone and quinone forms which are highly reactive (F, G). Quinone tautomerizes to form quinone-
methide and a,b-dehydrodopa, leading to the subsequent polymerization of the catechol group (H). Quinone also forms dimers
with another catechol moiety, resulting in dimer formation (I). Quinone reacts with nucleophiles (i.e., –NH2, –SH) found on tissue
surface, resulting interfacial covalent crosslinking (J).
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cuticles during the large, cyclic strains experienced by the bys-
sus in the turbulent intertidal zone.54,55 This complexation
chemistry has been exploited in creating self-healing hydro-
gels,56–58 pH-responsive drug carrier,59 soft actuators,60–62 and
mechanically reinforced polymeric fibers.63,64
In addition to forming strong complexes with metal ions, cat-
echol forms strong, reversible interfacial bonds with metal
oxide surfaces [Fig. 2(E)].65–67 The pull-off force required to
separate a single Dopa molecule from titanium (Ti) averaged
around 800 pN, which approaches 40% the bond strength of
a covalent bond (2000 pN for a carbon–silicon bond).68 This
is the strongest reversible bond reported in the literature
involving a biological molecule. According to density func-
tional theory analysis, the catechol groups readily compete
with water molecules and adsorb directly onto the metal
oxide surfaces with binding energy of 20–30 kcal/mol.69,70
Catechol’s ability to attach to various metal substrates (e.g.,
Au2O3, Al2O3, SiO2 TiO2, NiTi, and stainless steel), makes it
an ideal anchoring group for surface modification.71–73 How-
ever, the binding strength of the catechol to metal substrates
is highly dependent on its oxidation state, and its binding
strength is drastically reduced when the catechol is
oxidized.66,68,74
Oxidation-Mediate Covalent Crosslinking
When catechol is oxidized, it becomes highly reactive and can
participate in intermolecular covalent crosslinking, resulting
in the curing of Dopa-containing adhesives. Catechol can be
oxidized to form semiquinone [Fig. 2(F)] and quinone [Fig.
2(G)] by one-electron and two-electron oxidation, respectively,
through autoxidation in the presence of molecular oxygen or
the addition of either chemical (e.g., periodate) or enzymatic
(e.g., tyrosinase, peroxidase) oxidants.1,75 Quinone can tauto-
merize to form quinone methide and then to a,b-dehydro-
Dopa,76 resulting in the subsequent dimer formation and poly-
merization of the Dopa residues [Fig. 2(H)].77 Additionally,
crosslinking of the quinone with other catechol groups leads to
dimers formation and subsequent polymerization of the cate-
chol groups [Fig. 2(I)].1,75 Finally, quinone can also react with
various nucleophilic functional groups (i.e., –NH2, –SH, imidaz-
ole) found on biological substrates, forming interfacial covalent
bond [Fig. 2(J)].68,78,79
Oxidation of catechol amine with a free primary amine group
(e.g., dopamine) results in intra-molecular cyclization and
polymerization resembling melanin formation.77 The poly-
meric form of dopamine or polydopamine has the capability
of attaching to various types of surfaces ranging from noble
FIGURE 3 Schematic illustration of the adhesion of Mfp-3 and 5 in the presence of Mfp-6. Oxidation of catechol (A) and the forma-
tion of dithiol bonds (B) in Mfp-6 counteract the autoxidation of catechol in Mfp-3/5 to quinone to enhance the adsorption of Mfp-
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metals to inert polymers and ceramics80 with different
geometry and sizes.81–83 The amine group found in the poly-
dopamine film has been found to contribute to the cohesive
force formed between polydopamine films.84 Additionally,
polydopamine coating remains reactive and can be further
modified with functional groups (i.e., ANH2, ASH, etc.) or
metal ions.80,82,85 Antifouling polymers such as PEG and algi-
nate can graft on polydopamine-coated surfaces for design-
ing antifouling surfaces that prevent non-specific attachment
of cells and bacteria.80,86
The oxidative crosslinking of catechol is dependent on multiple
factors, which include the type of oxidant, the concentration of
oxidant, and pH. For example, enzyme-induced crosslinking
results in the polymerization of phenyl groups [Fig. 2(I)] and,
the rate and degree of polymerization increase with increasing
enzyme concentration.77 On the other hand, periodate-
mediated crosslinking involves the polymerization of a,b-dehy-
dro form of the catechol [Fig. 2(H)], with a maximum rate of
crosslinking occurring at periodate to catechol molar ratios
between 1 and 0.5.77,87 Additionally, the rate of crosslinking
increases with increasing pH, due to an elevated conversion of
catechol to quinone at a more basic pH.87 On the other hand,
oxidation intermediate of catechol such as quinone methide is
more stable at a mild acidic condition (pH 5.7–6.7), and the
rate of crosslinking is retarded at an acidic pH.87,88 Similarly,
protonation of nucleophilic functional groups (e.g., pKa of e-
lysine 10) at an acidic pH limits their ability for covalent
crosslinking, resulting in reduced interfacial bonding between
catechol-containing adhesive and soft tissue surface at an acid-
ic pH.87 This reduced crosslinking capability at an acid pH may
restrict the application of the catechol in contact with mildly
acidic tissues (e.g., cancer cells (pH 7),89 skin (pH 4–6),90
subcutaneous tissues (pH 6.7–7.1),91 and dysoxic tissues due
to extensive hemorrhage or ischemia (pH< 7).92
During catechol oxidation, reactive oxygen species (ROS)
such as super oxide anion (O•2) and hydrogen peroxide
(H2O2) are generated.
93,94 Catechol-containing hydrogel
released 1022103 mM of H2O2 during a period of 48 h in
culture, which reduced cell viability.93 The cytotoxic effect of
ROS was prevented in the presence of catalase, indicating
that the release of ROS is a source of cytotoxicity of catechol
in culture.93,95 The biological effects of ROS are highly con-
centration dependent and can range from beneficiary (i.e.,
promote wound healing, antimicrobial effects) to detrimental
(i.e., chronic inflammation, tumor initiation) responses.96–99
Therefore, precise regulation of ROS generated from
catechol-containing biomaterial is necessary depending on
the intended application.
Contribution of Other Factors to Adhesion
Dopa is the main constituent of Mfps that contributes to
strong wet adhesion.100–103 However, recent findings
revealed other factors such as the redox chemistry, coacer-
vate formation, surface drying capability, and other proper-
ties of Mfps may also play a role. This section reviews the
contribution of these factors on interfacial binding.
Effect of Oxidation State of Catechol
The adhesive property of catechol is highly dependent on its
oxidation state.66,74,104 At an acidic pH where catechol exists
predominantly in its reduced form, catechol exhibits elevated
adhesive strength to inorganic substrates.102,105 When the
pH approaches and exceeds the first dissociation constant of
the catechol –OH group (pKa15 9.3),
106 the catechol side
chain autoxidizes to its quinone form with reduced adhesive
strength.66,68,74 The force required to separate a single mole-
cule of Dopa from Ti surface reduces by nearly 80% with
the oxidation of the catechol side chain.68 Similarly, addition
of chemical oxidants (i.e., periodate) irreversibly oxidizes cat-
echol, resulting in reduced adhesive properties.66,107
To counteract the mildly basic condition of seawater, the pres-
ence of Mfp-6 near the plaque-surface interface was proposed
to provide an antioxidant mechanism to preserve the reduced
form of catechol for enhanced adhesion (Fig. 3). Mfp-6 is rich
in cysteine residues with an unusually low content of Dopa
for an interfacial plaque protein.14,105 The reducing capacity
FIGURE 4 Schematic representation of self-coacervation
formed by a polyampholytic protein (i.e., Mfp-3s) with increas-
ing pH (A) and complex coacervation formed between oppo-
sitely charged polyelectrolytes (B) Reprint from ref. 112,
Copyright 2014, with permission from Elsevier, and like-
charged polyelectrolytes facilitated by the strong short range
cation–p interactions between catechol and cationic functional
groups (C).
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of Mfp-6 was recently reported to be 17 electrons per protein,
where nearly half of them (at least 8 electrons) were contrib-
uted by factors other than the cysteine residues and potential-
ly by the presence of the Dopa moieties.108 The redox-active
Dopa in Mfp-6 likely serves as a sacrificial antioxidant, and
when these catechols oxidize [Fig. 3(A)] Dopa residues in
Mfp-3 or Mfp-5 are reduced to its adhesive catechol state
[Fig. 3(C)].108 Similarly, oxidation of thiol functional groups in
the cysteine residues results in the formation of dithiol bonds
[Fig. 3(B)], which serves to preserve the reduced form of
Dopa in Mfp-3 and Mfp-5 [Fig. 3(D)].102
Another strategy employed by marine mussels to minimize
Dopa autoxidation is the presence of Mfp-3s at the plaque-
surface interface. Mfp-3s has a low post-transitional modifica-
tion of tyrosine to Dopa residues and a lower charge density
than Mfp-3f, making Mfp-3s to be a polar but hydrophobic pro-
tein.4 Mfp-3s has demonstrated a higher redox potential and
significantly lower loss of H-bonding interactions between its
Dopa residues and mica substrate when compared to the
hydrophilic Mfp-3f at a slightly basic pH.4 The hydrophobic
environment created by Mfp-3s shields Dopa from the basic
seawater, which retards Dopa oxidation and enhances the
adhesion of plaque proteins on inorganic surfaces.4
Coacervate Formation
Coacervation is the fluid–fluid phase separation of ionic poly-
mers or proteins from the aqueous solution.109 The coacervates
are driven by the coulombic attraction and the neutralization of
oppositely charged side chains found in polyelectrolytes, and
are further stabilized by hydrophobic forces.110,111 Coacervation
contributes to underwater adhesion as it increases polymer con-
centration in the coacervates, enhances wetting properties
through decreasing interfacial energy, and eases the adhesive
delivery by reducing viscosity.101
Two different coacervation systems have been reported thus
far; self-coacervation and complex coacervation (Fig. 4). Self-
coacervation is the formation of coacervates by a single spe-
cies of polymer, which has been demonstrated by the highly
charged yet hydrophobic Mfp-3s [Fig. 4(A)].4 Plaque proteins
are delivered at an acidic pH, at which point the net positively
charged Mfp-3s is highly soluble. When the pH increases to
the pI of the protein (pI 7.5), the ionic residues are neutral-
ized and the decreased electrostatic repulsion between the
proteins resulted in self-coacervation.112 Similarly, increasing
the ionic strength of the solution resulted in a similar effect.
Additionally, the coacervates are further stabilized by the
hydrophobic residues of Mfp-3s, as more than 60% of its ami-
no acid residues are more hydrophobic than glycine.4
Complex coacervation involves the formation of coacervates
when a polyanion and a polycation neutralize one another
due to the strong electrostatic interaction between the two
oppositely charged polyelectrolytes [Fig. 4(B)]. Recently, Kim
et al.113 reported the coacervation of two positively charged
FIGURE 5 Proposed adhesion mechanism of catechol groups in a coacervate binding to underwater metal oxide surface through
the displacement of interfacial water molecules, and the formation of interfacial co-ordination and hydrogen bonds (inner-sphere
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polyelectrolytes [Fig. 4(C)]. Like-charged complex coacerva-
tion occurred through the formation of a strong short-range
cation–p interactions between benzene ring of Dopa in a
recombinant mussel foot protein 1 (rMfp-1) and cation in
poly(2-(trimethylamino)ethyl methacrylate, which overcame
the long-range electrostatic repulsion.
Surface Drying Properties
The presence of a layer of absorbed water in between the
adhesive and the surface interferes with interfacial molecular
contact and results in a strong hydration repulsive force
which hinders adhesion.114 Recent findings suggest that the
hydrophobic Mfp-3s can overcome the repulsive hydration
force by spontaneously “dry” the wetted surface before adhe-
sion.115 The hydrophobic side chains such as tryptophan res-
idues in Mfp-3s have been found to contribute to the
removal of the surface hydration layer.115
Additionally, the exceptional surface wetting properties of
Dopa116 and the ability for Mfp-3s to undergo self-coacerva-
tion115 have also been suggested to contribute to the drying
of the surface. Using homologues of Mfp-3s, Wei et al.116
demonstrated that only Dopa-containing coacervates have
the ability to displace interfacial water molecules from the
surface due to its high wetting properties which significantly
improve wet-adhesion properties of the peptide by promot-
ing the formation of molecular hydrogen bonds. Upon
removing the water molecules from the metal oxide surface,
catechol–metal co-ordination and hydrogen interactions
results in the formation of inner-sphere surface complex fol-
lowed by the formation of electrostatic interactions and cre-
ating outer-sphere complexes (Fig. 5).116
Bridging Adhesion
The ability for an adhesive to bridge two adherent substrates
has also been found to contribute to adhesion. Using surface
forces apparatus (SFA), Mfp-3 (16 mol% Dopa) exhibited
adhesion energy of 30 mJ/m2, effectively gluing two mica
surfaces together. On the other hand, minimal adhesion was
detected for Mfp-1 despite having similar Dopa content
(12 mol %).117 Mfp-3 exhibited the ability to bridge two
mica surfaces, whereas Mfp-1 was predominantly bound to
only one of the two surfaces. Peptide chain length is another
factor that significantly affects the bridging adhesion (Fig. 6).
Shorter peptides have fewer bridging opportunities as they
may attach solely to one surface.44 Doubling the peptide
chain length have been reported to double the magnitude of
bridging adhesion to two mica surfaces.
Strong bridging adhesion can be obtained even for shorter
peptides, if one of the surfaces does not solely rely on Dopa-
mediated adhesion (i.e., hydrogen and co-ordination bind-
ings).44 Additionally, Mfps demonstrate enhanced adhesion
energy when bridging two asymmetric surfaces (e.g., mica
and methyl (CH3)-terminated self-assembled monolayer) as
opposed to between two symmetric surfaces (e.g., two mica
surfaces) as the adhesive proteins can partition their
domains of chemically effective residues between two dis-
similar surfaces for strong interfacial binding to theses surfa-
ces.118 Incorporation of lysine residues promoted adhesion
to mineral surfaces, due to its ability to displace surface cati-
ons which assisted the catechol groups to form strong hydro-
gen bonding.119 Similarly, electrostatic interaction is one of
the factors that promote bridging adhesion of Mfp-5 on two
mica surfaces due to its long-range interaction in comparison
with Dopa-mediated surface absorption, which requires the
geometry of attachment site for the formation of co-
ordination and hydrogen bonds.44
FIGURE 6 Schematic representation of peptide monomer (A) and dimer (B) adhering to mica substrates. The peptide dimer with a
longer chain length is capable of bridging two mica surfaces and demonstrated enhanced adhesion.
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Catechol-Modified Side Chain
Similar to marine mussels, Dopa has also been found in
adhesive proteins secreted by sandcastle worms to cement
sand fragments into tubed-shaped dwellings.120 In these
adhesive proteins, para proton (–H) in the catechol side
chain is substituted with a chloro-functional group which is
considered as a natural adaptation to increase interfacial
binding strength [Fig. 7(A)].120 Similarly, catechol side chain
modified with an electron withdrawing nitro-groups signifi-
cantly increased the reactivity and interfacial binding
strength of the catechols [Fig. 7(B)].121 Nitro-catechol bound
to an inorganic surface exhibited increased resistance to ele-
vated temperature and oxidation when compared to an
unsubstituted catechol.122–124 These modifications lowered
the dissociation constants (pKa) of the catechol hydroxyl
groups, which promoted the formation of catechol–metal ion
complexes at a reduced pH and with a higher stoichiome-
try.123,125 Additionally, nitro-catechol exhibited increased rate
of covalent crosslinking, bound to biological substrates over
a wider range of pH, and increased the rate of adhesive deg-
radation when compared to unmodified catechol.121,126 Fur-
thermore, nitro- and chloro-functionalized catechols were
reported to exhibit unique properties such as light-induced
degradation127 and antimicrobial characteristics,128 respec-
tively. Similarly, pyridine modified quinone [Fig. 7(C)] has
also formed strong metal ion complexes125 as well as
enhanced interfacial binding strength to inorganic
substrates.123,124
The adhesion of –OH modified catechol groups [Fig. 7(D,E)]
has also been reported125 and these trioxyphenyl moieties
have demonstrated the capability of forming strong com-
plexes with metal ions129 and boronic acid.130 Tannic acid is
a natural polyphenol consisting of trihydroxy phenol moie-
ties. Tannic acid is capable of forming a colorless coating for
subsequent surface modifications to create antibacterial and
antioxidant surfaces,131 and has been utilized in creating
nanoparticles for entrapping and stabilizing anticancer
drug.132
STRATEGIES FOR PREPARING CATECHOL-FUNCTIONALIZED
ADHESIVE POLYMERS
Functionalizing synthetic, inert polymers with Dopa and
various catecholic derivatives has been utilized to develop
functional adhesive polymers with strong wet adhesive prop-
erties and the ability to cure rapidly. Dopa-functionalized
polymers have been prepared through five general strategies
including direct functionalization of polymers with catechol,
polymerization of catechol-modified monomers, the use of
catechol-functionalized initiator to polymerize synthetic
monomers, creating Dopa-containing peptides through solid-
phase peptide synthesis approach, and recombinant genetic
engineering techniques. These strategies are described in
this section.
Protection of Catechol Groups
The first step in preparing catechol-functionalized polymers
involves the preservation of the catechol side chains against
oxidation and undesirable chemical reactions during the pro-
cess of synthesis, which may diminish their reactivity. A
desirable protecting group should remain stable during the
synthetic chemical reaction while the deprotection technique
should be chosen based on the composition of the final
polymer so that its functionality is not reduced during the
FIGURE 7 Chemical structure modified catechol side chain with the proton (-H) at the para position replaced with a chloro- (A)
and nitro- (B) functional group, the benzene ring was substituted with a pyridine group (C), and the proton substituted with a
hydroxyl group at the meta (D) and para (E) positions of the benzene ring.
FIGURE 8 Strategies for preparing catechol-modified polymers
of different architecture with functional groups such as ANH2,





10 JOURNAL OF POLYMER SCIENCE, PART A: POLYMER CHEMISTRY 2016, 00, 000–000
process. For multi-step chemical synthesis approaches, pro-
tecting groups such as acetyl,66 acetonide,133,134 methyl
ether,135 cyclic ethyl orthoformate (Ceof),136 carboxyben-
zyl,137 and t-butyldimethylsilyl (TBDMS)138 have been uti-
lized. Additionally, catechol forms pH responsive complex
with boronic acid, which can act as a temporary protecting
group in a basic aqueous solution.138,139 Similarly, triethylsi-
lane has also been used for protection of hydroxyl (AOH)
and methyl ether side chains of a natural phenolic com-
pound, eugenol,140 which has antimicrobial, antifungal, anti-
oxidant, and anti-inflammatory properties141–143 and has
widely been studied for dental applications.144,145
Direct Functionalization of Polymers with Catechol
Catechol such as Dopa and dopamine can be directly coupled
to polymers with functional groups such as ANH2, ACOOH,
and AOH, through the formation of amide,77 urethane,146
and ester147 linkages (Fig. 8). This strategy can be adopted
to functionalized polymers, such as poly(ethylene glycol)
(PEG), with different polymer architectures (i.e., linear and
branched), where catechol is attached as terminal functional
groups. PEG is a biocompatible, hydrophilic, and inert poly-
mer which has been used for various biomedical applications
such as antifouling coatings,71,146 bioadhesives, and
sealants.148,149
Additionally, branched and linear PEG can be linked with
polycaprolactone (PCL)150,151 and polypropylene oxide
(PPO)146,152 polymers to form block copolymers which can
be further grafted with catechol along its polymer chains.
These block copolymers have demonstrated improved
material properties through the self-assembly of the hydro-
phobic blocks,150,151 as well as thermal responsivity146 and
desirable swelling properties.152 Similarly, block copolymers
composed of PEG and polymers such as poly(methyl meha-
crylate)153 and poly(methacrylate)107 as well as polyure-
thane of PEG and oligo alkyl chains154 have also been
reported. Furthermore, acid- or amine-functionalized cate-
chol can be covalently attached to biopolymers such as
dextran,155 chitosan,156 hyaluronic acid,157 gelatin,158 and
alginate159 to form bioadhesives which are well suited for
tissue engineering and drug-delivery applications.
Eugenol also can be directly coupled with wide variety of
polymers through its active terminal alkene group using
thiol-en chemistry.140 The protected eugenol can be end-
functionalized with thiol to create a catechol protected
monomer, which can be used to link to a polymer with a
desired architecture.160,161 For example, random copolymers
of poly(styrene-co-(4-ethynyl styrene)), which contain an
active alkyne group have been functionalized with eugenol
through thiol-yne reaction to create catechol-functionalzed
polystyrene.162
Polymerization of Catechol-Modified Monomer
Catechol-modified monomers, such as dopamine methacryla-
mide (DMA) [Fig. 9(A)],138,139,158 can be polymerized
through heat-activated or photo-initiated free-radical poly-
merization to form acrylate-based polymers [Fig. 9(a)]. Vari-
ous monomers such as oligomeric ethylene glycol,163
monoacryloxyethyl phosphate,164 and methoxyethyl acry-
late139 have been copolymerized with DMA to form
FIGURE 9 Catechol modified with polymerizable methacrylate (A), vinyl (B), and N-carboxyanhydride (C) functional groups. Poly-
merization of catechol-modified monomers to form linear homopolymer or random copolymer (a), block copolymer in the pres-
ence of polymer end-functionalized initiator (b), and a three dimensional polymer network in the presence of bi-functional
crosslinker (c).
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dopamine grafted polymers with a broad range of physical
characteristics, molecular weights, and catechol contents. In
a similar manner, polystyrene-based copolymers can also be
created through copolymerization of catechol-containing
vinyl group (e.g., 3,4-dihyroxystyrene [Fig. 9(B)], 4-
vinylcatechol acetonide, and 3-vinylcatechol acetonide) and
styrene.135,165–168 A three dimensional polymer network can
be formed from the copolymerization with a bi-functional
crosslinker (e.g., N,N0-methylenebisacrylamide) to form a net-
work with catechol covalently tethered to its backbone [Fig.
9(c)].93,169
In the presence of molecular oxygen, the catechol side chain
partially inhibits and retards free-radical polymerization.138
As such to minimize the inhibitive effect of oxygen the use of
catechol protection groups135 or the elimination of molecular
oxygen139 are required to form polymers with high catechol
content and molecular weight (MW). Similarly, separating
catechol side chain from the polymerizable acrylate group
using the ability of block copolymers to self-assemble into
hydrophilic and hydrophobic domains have also been
reported to be an effective approach.66
Water soluble copolypeptides have been created through
ring-opening polymerization of N-carboxyanhydride [NCA,
Fig. 9(C)] of lysine and Dopa, which have been reported to
have high bonding strength and high MW’s as well as
narrow MW distributions.137,170 Additionally, in the presence
of polymer end-functionalized with an initiator (i.e., ANH2),
block copolymers with poly(DOPA-lysine) and oligomeric
poly(DOPA) copolypeptide have been created [Fig. 9(b)].66
Most recently, catechol-modified with an epoxide monomer
(i.e., acetonide glycidyl ether) have been copolymerized with
ethylene glycol to create linear PEG-based block copoly-
mers.171 Similarly, copolymerization with glycidol resulted in
the formation of a hyperbranched copolymer. These copoly-
mers have the ability to form hydrogel networks in the pres-
ence of Fe13 metal ions under basic condition and
demonstrated the ability for surface modification.
Catechol-Functionalized Initiator for Polymer Synthesis
Catechol-modified initiators have been utilized to create
polymer end-functionalized with the adhesive moiety
(Fig. 10). Dopamine functionalized with reversible addition-
fragmentation chain transfer (RAFT) agent [Fig. 10(A)] has
been used as an initiator to prepare polymers such as poly-
styrene, poly(N-isopropylacrylamide), and poly(tert-butyl
acrylate) end-modified with a catechol moiety.172,173 Similar-
ly, catechol functionalized with alkyl bromine [Fig. 10(B)]
has been used as an initiator to synthesize poly(mathacry-
late)- and poly(acrylate)-based polymers through atom trans-
fer radical polymerization (ATRP).174–177 Ring-opening
metathesis polymerization (ROMP) has also been used to
prepare catechol-modified poly(pentadecafluorooctyl-5-
norbornene-2-carboxylate) from dopamine functionalized
with ROMP agent [Fig. 10(C)].178 Beside dopamine-
functionalized initiator, the use of poly(DOPA-lysine) oligo-
peptide functionalized-initiator has also been reported.179
Solid-Phase Peptide Synthesis
Dopa-containing peptides have been prepared through solid-
phase peptide synthesis method using Dopa residues
where its primary amine and the catechol side chain are pro-
tected.136,180,181 tert-butyloxycarbonyl (Boc) and 9-
fluorenylmethyloxycarbonyl (Fmoc) are two of the most
common protecting groups for the a-amino group.136,180
However, Fmoc is preferable due to a cleaner synthesis and
peptide products as well as the ability to avoid the use of
strong acid.182 The catechol side chain is typically protected
using acid-liable groups such as TBDMS,183 tert-butyldiphe-
nylsilyl,180 Ceof,136 and acetonide,133 which have been
demonstrated to be compatible with solid-phase peptide syn-
thesis protocols.
Peptoids have a peptide-like backbone with side chain sub-
stitution on the amide nitrogen instead of the a-carbon,
which increases their resistance against protease degrada-
tion.184 Solid-phase peptide synthesis strategy has been used
to synthesize peptoids end-modified with Dopa-containing
peptide, which demonstrated long-term antifouling proper-
ties when coated on a titanium surface.185
Recombinant Genetic Engineering
Dopa-containing peptides have been prepared through
recombinant DNA technology to replicate peptide sequences
FIGURE 10 Schematic representation of catechol-functionalized
initiator to prepare polymer end-functionalized with catechol.
Chemical structures of catechol-functionalized initiator using
RAFT (A) ATRP (B), and ROMP (C) polymerization. R represents
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found in various Mfps.186–188 Peptides are produced with
tyrosine residues in bacteria (e.g., Escherichia coli), which are
further converted to Dopa using tyrosinase to generate func-
tional adhesive peptides.188 Although, this technology cannot
produce full-length native foot proteins due to their length
and highly repetitive sequences, recombinant peptides have
been investigated as wet bioadhesives,189,190 coatings,190 and
self-healing hydrogels.191
One of the unique features in using the recombinant tech-
nique is the ability to combine sequences from different
Mfps to generate hybrid peptides. For example, sequences
from both Mfp-5 and Mfp-1 have been used to create ABA
block copolypeptide, where “A” and “B” blocks each contain
separate sequences from these two proteins.189 Similarly,
hybrid copolypeptides have been created to contain sequen-
ces from both Mfp-1 and -3.192 Sequences from Mfp-1 and -3
have also been combined with protein sequences from E. coli
fiber-forming amyloid to form a chimeric peptide that is
capable of self-assembling into higher-ordered, adhesive
nanofibers.193 Peptides containing Mfp sequences have
also been created with a RGD peptide sequence found in
fibronectin, to promote cell attachment.194 However, limita-
tions of using recombinant DNA techniques to generate bio-
adhesives include low yields, requiring post-transitional
modification to generate catechol moiety, low efficiency
in the modification of tyrosine to Dopa, and lacking other
post-translationally modified amino acids (e.g.,
hydroxyproline).186,189,195
RECENT POLYMER SYSTEMS INCORPORATING NOVEL
BIOMIMETIC DESIGNS
Coacervated Dopa-Functionalized Polymer Adhesives
Inspired by Mfp-3s’s ability to form self-coacervate in pro-
moting adhesion and increasing Dopa’s oxidation potential,4
a series of ampholytic copolymers composed of varying
amounts of amphiphilic and ionic functional groups found in
Mfp-3s (i.e., anionic, cationic, nonionic hydrophilic, and non-
ionic hydrophobic co-monomers) have been synthesized to
study the effect of these functional groups on microphase
behavior and wet adhesion properties.110 These Mfp-3s-
mimetic polymers demonstrated the ability to self-coacervate
and uniformly spread over a surface. Additionally, binding
energy was reported to be doubled (30 mJ/m2) by increas-
ing pH to 7 after delivering the adhesive solution at pH 4
without the use of oxidative crosslinking. These adhesive val-
ues are nearly an order of magnitude higher than those
found for natural Mfp-3s. To combine the self-coacervation
capability of Mfp-3s and the strong adhesive properties of
Mfp-5, a low MW catecholic zwitterionic surfactant has also
been synthesized, which demonstrated strong wet-adhesion
and the ability to self-coacervate.111
Complex coacervation formed between polymers and pepti-
des has also been explored for developing new coacervates
for various biomedical applications.113,190,196 Coacervates
have been formed between cationic recombinant peptides
and anionic hyaluronic acid (HA), which demonstrated favor-
able adhesive spreading properties over the targeted surface
and wet-adhesion properties.190,197 Recently, pH responsive
adhesive coacervates have been developed by combining
Zn21 ion with Dopa-modified poly(acrylic acid) (PAA-
Dopa).196 The PAA-Dopa solution was injected at a low pH
into the zinc solution which formed dense coacervates as a
result of electrostatic interaction between zinc chelated
mono-catechol groups and negative charged carboxyl groups
of PAA. The coacervate then gelled when the solution pH
was increased to 9 due to oxidation of catechol groups
which enables the formation of bis-catecholate-Zn12 com-
plexes. This coacervate system exhibited excellent adhesive
and self-healing properties after gelation, and has the poten-
tial for localized drug-delivery application.
Nano- and Micro-composite Adhesive Hydrogel
Hydrogels are highly hydrated three dimensional polymer
networks and can be used in various biomedical applica-
tions, including drug-delivery vehicles,198 actuators,199 and
tissue adhesives.151 However, hydrogels are fragile, which
FIGURE 11 Schematic illustration of composite adhesive con-
sisted of PEG-catechol containing either a nano-silicate, Lapon-
ite, or gelatin microgels. Catechol forms reversible non-
covalent crosslinking with Laponite (A) and irreversible cova-
lent crosslinking with functional groups (e.g.,–NH2, –SH) found
on the gelatin microgels, (B) contributing to the increased bulk
mechanical properties of the adhesive. Catechol also polymer-
izes (C) and reacts with nucleophilic groups found on tissue
surface (D), resulting in rapid curing of the adhesive and inter-
facial binding, respectively.
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limits their uses in most load-bearing applications. The
incorporation of inorganic nanoparticles into an organic
polymer network has been shown to increase the material
properties of the hydrogel network.200–202 Laponite, a nano-
silicate, was incorporated into a chemically crosslinked poly-
acrylamide (PAAm) nano-composite hydrogels containing
DMA.169 This nano-composite hydrogel can be repeatedly
compressed to a strain of 0.8 while demonstrating compres-
sive stress of over 1 MPa.
Laponite was incorporated into a branched PEG-terminated
with dopamine to create an injectable bioadhesive with
improved mechanical and adhesive properties (Fig.
11).203,204 Additionally, Laponite provided binding sites for
cellular attachment and promoted tissue ingrowth when the
adhesive was implanted subcutaneously.203 Additionally, oth-
er types of nanoparticles (i.e., iron- and silver-based) have
been used to create mechanically enhanced hydrogels, which
provided additional functionality into the nano-composite
system (e.g., ability to respond to applied magnetic field and
antimicrobial properties, respectively).205,206
The mechanical properties of catechol-containing nano-com-
posite hydrogels are highly dependent on the strength of
interaction between the catechol moiety and the encapsulat-
ed nanoparticles.122 The oxidation state of catechol greatly
influences its interfacial binding properties to inorganic
surfaces.66,74,104 As such, catechol’s adhesive properties
decrease with increasing pH as it is progressively autoxi-
dized to form the more poorly adhesive quinone.74 Shear
moduli of dopamine-modified nano-composite hydrogel was
demonstrated to be lower at pH 9 when compared to values
obtained at a neutral to acidic pH.122 Similarly, when dopa-
mine was replaced with nitrodopamine that binds more
strongly with inorganic substrates, shear moduli of the nano-
composite hydrogel increased.122 Nitrodopamine was also
less prone to autoxidation and exhibited stronger binding to
the nanoparticles even at a basic pH.
In addition to inorganic nanoparticles, incorporation of
gelatin-based microparticles into dopamine-functionalized
PEG-based adhesive has also demonstrated improved
mechanical properties (Fig. 11).207 Gelatin is the denatured
form of collagen often used for biomedical applications.208
Gelatin contains nucleophilic side chains (i.e., ANH2 and
ASH from lysine and cysteine, respectively) that enabled gel-
atin microparticles to be chemically incorporated into the
PEG network through covalent bond formation with oxidized
catechol (i.e., quinone) found on dopamine [Fig. 11(B)].207
Additionally, gelatin microparticles retained the triple helix
structure of collagen.209,210 This provided reversible, physical
interaction in the PEG network and improved the viscous
dissipation properties to the micro-composite hydrogel. Most
importantly, gelatin provided binding sites for cellular attach-
ment and a pocket for cellular infiltration in vivo, which are
critical for improving healing responses.207
Hydrogel Actuator
Hydrogel actuators change their shapes and physical proper-
ties in response to environmental stimuli (i.e., temperature,
FIGURE 12 Schematic illustration of self-healing hydrogels containing catechol through the formation of catechol–metal ion com-




14 JOURNAL OF POLYMER SCIENCE, PART A: POLYMER CHEMISTRY 2016, 00, 000–000
pH, etc.).211 The ability for catechol to transition reversibly
between metal ion complexes [Fig. 2(D)] of different stoichi-
ometry (i.e., mono- vs. tris-catecholate complexes) in
response to pH was exploited to create a pH-responsive
actuator.62,212 DMA-containing hydrogel was locally iono-
printed with ferric ions (Fe13), which increased local cross-
linking density at the ionoprinting site and resulted in the
sharp bending of the hydrogel.62 Hydrogels can transform
into different three dimensional geometries depending on
the ionoprinting pattern. Additionally, the metal ions are
reversibly bound to the catechol and can be removed using
ethylenediaminetetraacetic acid, so that metal ions can be
reintroduced into a new pattern.62 The rate and extent to
which hydrogel can actuate is considerably tunable by differ-
ent factors including catechol and metal ion content, pH,
hydrogel thickness, and metal ion type (Fe13, Al13, Cu12,
Zn12, and Ti14).60,61 Specifically, using different metal ions
enabled different sections of the hydrogels to actuate at dif-
ferent rates, achieving sequential folding.
Self-Healing Hydrogels
The ability for catechol to form various strong reversible
bonds has been utilized to design self-healing hydrogels (Fig.
12). Metal-catechol co-ordination bond has been employed
to design pH-responsive self-healing hydrogels by mixing
catechol-containing polymers and peptides with various met-
al ions such as Fe31, Zn21, V13, Al31, Ga31, and In31 under
basic condition [Fig. 12(A)].56,57,213,214 These self-healing
networks exhibited elastic moduli values approaching those
of covalently crosslinked hydrogels at high strain rate.56 Cat-
echol–boronate complex has also been utilized to create sim-
ilar pH-responsive self-healing hydrogels that exhibited high
stability in an alkaline pH [Fig. 12(B)].215
A mussel inspired polymer with the ability to heal under
acidic conditions has also been reported.216 Polyacrylate and
polymethacrylate surface-functionalized with triethylsilyl-
protecting catechols demonstrated self-healing properties
under slight compression and acidic condition (pH 3). The
catechol protecting groups were removed under acidic condi-
tions resulted in the formation of hydrogen bonds between
interfacial catechol groups and self-healing of the polymer
[Fig. 12(C)]. Recently, an injectable, thermosensitive catechol
functionalized ABA tri-block copolymer composed of poly(N-
isopropylacrylamide) as thermosensitive “A” block and PEG
as water-soluble “B” block has been prepared.217 The hydro-
gel self-healed from deformation through the formation of
hydrogen bonds which facilitated the self-healing process.
Compare with self-healing hydrogels based on catechol-metal
ions co-ordination which may be toxic when used in vivo,
this metal-free hydrogel is capable of tolerating high strain
and also fast recovery of its mechanical properties after
repeated deformation; thus, exhibited great potentials for
various biomedical applications such as drug delivery.
Smart Adhesives
Smart adhesives can transition reversibly between its adhe-
sive and non-adhesive states in response to externally applied
stimuli. These tunable adhesive properties have been met
with significant interests in various fields of materials science
and engineering, including manufacturing, robotic locomotion,
and wound dressings.218–221 However, existing smart adhe-
sives are limited by the need for extreme conditions to pro-
mote transition (e.g., elevated temperature219), adhesion to a
limited substrate types,222 or reduced interfacial binding
strength to wetted surfaces.220 Smart adhesives that combine
the moisture-resistant adhesive properties of Dopa-based
chemistry have recently been reported. Catechol has been
coupled to light-degradable polymer consisting of di-o-nitro-
benzaldehyde and the adhesive degraded in response to ultra-
violet light irradiation.223 Similarly, nitrodopamine-modified
PEG is photosensitive and the cured adhesive degrades when
exposed to light.127 Tyrosine-functionalized adhesives can be
activated to their adhesive catechol form with the addition of
tyrosinase, which transforms the non-adhesive tyrosine resi-
dues into the adhesive Dopa residues for adhesion.224,225
FIGURE 13 Schematic representation of the smart adhesive containing catechol and phenylboronic acid functional groups. At an
acidic pH, both the catechol and borate functional groups contributed to strong interfacial binding with the wetted borosilicate
substrate (A). In a basic pH, formation of catechol–boronate complexation reduced the interfacial binding strength of the adhesive
(B). Changing the pH, effectively converts the smart adhesive between its adhesive and non-adhesive states. Reprinted with per-
mission from ref. 226,Copyright 2016 American chemical society.
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Although these catechol-containing smart adhesives demon-
strated moisture-resistant adhesive properties, they are not
reversible (i.e., one-time activation or one-time deactivation).
Most recently, our lab exploited the reversible catechol–boro-
nate complexation chemistry [Fig. 12(B)] to create a revers-
ible smart adhesive that transitioned reversibly between its
TABLE 2 A Brief Summary of the Preparation Strategies, Composition, and Intended Applications of Catechol-Functionalized Adhe-
sives Polymers
Preparation Strategies Composition Intended Applications References
Direct functionalization Catechol-functionalized:
 Linear and branched PEG Biomedical adhesive and sealant 146, 150–152
 Block copolymer of PEG and
PCL or PPO
 PEG based triblock copolymer Antifouling/cell-resistant coating 160
Self-healing hydrogel 217
 Light-degradable polymer Smart adhesive 223
Dopa-functionalized:
 PEG-based polymer Self-healing hydrogela 56, 57, 213





Copolymerization of: Biomedical adhesives/wound
healing
93, 163, 169
 DMA With various monomers Antifouling/bacteria-resistant 138
Smart adhesive 226
Actuatorb 60–62
 Eugenol with other monomers Coacervates 110
Polymerization of:
 eugenol acrylates and eugenol
methacrylates









Antifouling coating grown from
dopamine-functionalized:
 ATRP agent Antifouling/cell-resistant, bacteria-
resistant coating
174–177
 ROMP agent Water and oil resistant coating 178
Solid phase peptide synthesis  Dopa-containing peptide and
antifouling polymer
Antifouling/cell-resistant coating 71
 Peptoid modified with Dopa-
containing peptide
Antifouling/cell-resistant coating 185
 Short peptide analogue Mfp-
3s
Coacervate adhesive 116
Recombinant genetic engineering  RMfp-3,RMfp-5, 187–189
 hybrid copolypeptide of Mfp-1
and Mfp-5
Biomedical adhesive
 RMfp-1 hydrogel Self-healing hydrogela 191
 Peptides containing Mfp
sequences with a RGD pep-
tide sequence found in
fibronectin
Coacervate adhesivec 190, 194
Biomedical adhesive
a In the presence of metal ions.
b Ionoprinting with metal ions.
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adhesive and non-adhesive states.226 This adhesive contained
network-bound dopamine and phenyl boronic acid that
formed strong interfacial bonds with wetted glass surface at
pH 3 (Fig. 13). When the pH was increased to 9, formation
of the catechol–boronate complex reduced the measured
work of adhesion by more than an order of magnitude. The
boronic acid also served as a protecting group to prevent the
irreversible oxidation and crosslinking of catechol, so that
the adhesive can reversibly transition between its adhesive
and non-adhesive states.
BIOMEDICAL APPLICATIONS OF BIOMIMETIC POLYMER
ADHESIVES
The unique and robust interfacial chemistry of catechol pro-
vide scientists a tool to design various bioadhesive materials
for a wide range of biomedical applications. Table 2 summa-
rizes various strategies for preparing catechol-functionalized
polymers for various biomedical applications reviewed here.
Biomedical Adhesives
Tissue adhesives can simplify surgical procedures and mini-
mize trauma typically associated with the use of suture and
staples.228,229 However, commercially available adhesives are
limited by slow degradation rate, toxicity concerns, and poor
adhesive strength.230–232 PEG-based adhesives are one of the
popular synthetic adhesives that have been used for various
surgical applications such as dural,233 pulmonary,234 and car-
diovascular235 surgeries. Dopa- and catechol-modified PEG-
based adhesives are one of the earliest synthetic bioadhe-
sives that have been developed, which exhibited potential in
various applications including sealing of fetal membrane,236
sutureless wound closure,147 and cell engineering.147 These
adhesives demonstrated superior adhesive properties when
compared to commercially available fibrin- and PEG-based
glue. However, due to the hydrophilicity of PEG, PEG-based
adhesives swell excessively, which reduces mechanical prop-
erties and may lead to complications (e.g., local nerve
compression).152,237
Incorporating thermosensitive tetronic polymers as the back-
bone of polymeric bioadhesives is one of the promising
approaches to control the swelling behavior of the adhesive
hydrogel.152,238 Tetronic is a branched, multi-block copoly-
mer consisting of a central hydrophobic PPO block and
peripheral hydrophilic PEG blocks and demonstrated deswel-
ling behavior when heated. Tetronic end-functionalized with
catechol exhibited enhanced mechanical toughness and sys-
tematically controllable deswelling of the adhesive (0–25%),
due to the self-assembling capability of the PPO block.152
Enhanced bulk mechanical properties of tetronic-based adhe-
sive also resulted in increased lap shear adhesive strength to
decellularized porcine dermis when compared to PEG-based
adhesives.
A PEG-citrate-based polymer functionalized with dopamine
has been prepared by polycondensation reaction and demon-
strated the potential for sutureless wound closure.147 The
adhesive demonstrated adhesive strength that was 2.5–8.0
folds higher than that of fibrin glue, while exhibiting a
tissue-like elastomeric behavior and improved load bearing
and stress transferring properties. The adhesive also exhib-
ited controllable degradation rate (1–25 days) and excellent
biocompatibility. However, the use of PEG as the diol signifi-
cantly elevated equilibrium water content of the adhesive. To
modulate the swelling behavior, the adhesive was formulated
with hydrophobic 1,8-octanediol, which resulted in stronger
adhesive with improved swelling properties.239
Naturally occurring biopolymers such as silk fibroin, HA, and
chitosan functionalized with catechol have also been investi-
gated.240–244 Silk fibroin is a hydrophobic biopolymer with
repeated amino acid sequence of glycine, alanine, and serine
residues,245 and has recently attracted attentions as a bioma-
terial platform.246,247 A silk fibroin polymer purified from
silkworm fibers modified with catechol and PEG side chains
has demonstrated improved adhesive strength in comparison
with catechol-free silk as well as a lower degree of swelling
compared to PEG-based adhesive.240 This silk-based adhesive
also supported the attachment and proliferation of human
mesenchymal cells in culture.
HA is a natural non-sulfated glucosaminoglycan which has
widely been used for various biomedical applications, includ-
ing tissue regeneration and wound healing applica-
tions.248,249 HA grafted with dopamine demonstrated
excellent biocompatibility with enhanced wet adhesive prop-
erties.244 The HA-based adhesive successfully encapsulated
two types of cells (i.e., human adipose-derived stem cells
and hepatocytes) and demonstrated the potential for mini-
mally invasive cell transplantation. Encapsulated cell demon-
strated increased viability and functionality when compared
to those encapsulated in conventional hydrogels crosslinked
through photopolymerization. Similar to PEG-based biomate-
rials, HA swells excessively in an aqueous environment
which results in poor mechanical properties. To improve the
mechanical properties of HA-based hydrogels, dopamine-
modified HA were formulated with Pluronic, which is an
ABA triblock polymer consisting of hydrophilic PEG “A”
blocks flanking a hydrophobic PPO “B” block.250 This com-
posite adhesive demonstrated rapid and reversible sol–gel
transition and high stability both in vitro and in vivo.
Chitosan is a natural polysaccharide which has been used in
various biomedical applications such as wound closure251
and hemostatic252 applications. Hydrogels consisting of chito-
san and catechol-containing moieties (i.e., Dopa, hydrocaffeic
acid (HCA), and dopamine) were broadly investigated as a
mucoadhesive biomaterial.241–243 Chitosan-based bioadhe-
sives demonstrated strong adhesive properties to mucosal
tissues with minimal cytotoxicity. Chemically crosslinking the
catechol–chitosan-based adhesives with genipin demonstrat-
ed further enhancement in mucoadhesive properties and
stability.253
Therapeutic Applications
The unique ability for catechol to anchor to wide ranges of
surfaces in different length scale has been utilized to create
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biomaterials for various anticancer and antimicrobial appli-
cations. Gold nanoparticles exhibits unique optical properties
and can convert light energy into heat.254 Using polydop-
amine as a surface anchoring group, gold nanorods were
functionalized with epidermal growth factors receptor anti-
bodies (anti-EGFR) to target and selectively bind to cells
overexpressing EGFR, such as the cancer cells in the breast
and colon.83 Subsequent light irradiation resulted in consid-
erable heat production locally, resulting in photo-induced
cancer cell death. Similarly, polydopamine-coated gold nano-
rods were coated with silver nanoparticles and antibacterial
antibodies to specifically bind to both Staphylococcus epider-
midis and E. coli.255 Illumination of bacteria-bound gold
nanorods resulted in plasmonic heating and triggered release
of silver ions for dual antimicrobial effect.
Polydopamine coated on a sacrificial nanoparticle template
has been used to create a capsule with controllable size and
wall thickness after removing the template.256,257 The capsu-
les can be subsequently loaded with anticancer drugs for
their sustained release. However, this capsule lack the ability
for targeted and triggered release of the loaded drugs for
enhanced therapeutic efficacy. To create a pH-responsive cap-
sule, doxorubicin (Dox), an anticancer drug, was immobilized
onto polydopamine capsule using an acid-labile hydrazine
bond.258 Degradation of the hydrazine bond in the acidic
environment (pH 5–6) of the endosomal and lysosomal com-
partments within a cancer cell triggers the rapid release of
Dox.
Similar pH-responsive capsule was created using a tannic
acid–Fe31 ion complexation.129 This so called metal-phenolic
network (MPN) capsules are stable at a neutral pH due to
the formation of complexes with higher stoichiometry (3:1
tannic acid: Fe31 ion). At an acidic pH, formation of a com-
plex with a reduced stoichiometry (1:1 tannic acid: Fe31 ion)
resulted in the rapid disassembly of the capsules and release
of the encapsulated drugs. MPN with the ability to target
cancer cells was also created using the combination of
catechol-modified HA and PEG (Fig. 14).259,260 Incorporation
of PEG minimized nonspecific adsorption of proteins and
cells, while HA enhanced the binding and targeting abilities
of the capsules to cancer cells that overexpressed CD44
receptor. The HA to PEG contents can be optimized to create
capsules with high targeting capability to CD44 positive
cancer cells, while minimize binding to CD44 negative cells
[Fig. 14(B)].260
Paclitaxel (PTX) is a common anticancer drug which has
broadly been used for treating various cancers such as lung
FIGURE 14 Schematic representation of metal-phenolic network capsules (MPNHA-PEG) assembly consists of hyaluronic acid (HA)
and poly(ethylene glycol) (PEG) with three different HA/PEG ratios (A). HA enhances targeting and binding to CD441 (cancer cell
line, blue) while PEG minimizes nonspecific binding to CD442 (pink) cells (B). Reprinted with permission from ref. 260,Copyright
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cancer, but its application is limited by its poor solubility in
an aqueous solution.261 Strong complexes formed between
tannic acid and Fe13 ions have also been used to stabilize
the interface of nanoparticles composed of PTX.132 The stabi-
lized nano-drug particles are uniform in size (100–120 nm)
with high drug loading capability and long-term colloidal sta-
bility (longer than half a year).132
Antifouling Coating
Controlling interfacial adsorption of biomolecules, proteins,
and cells greatly affects the success of implanted biomateri-
als.262 Immobilizing antifouling polymers such as PEG on
device surfaces is a common strategy to reduce nonspecific
adsorption of cells and proteins.73,185 Catechol’s ability to
attach to both organic and inorganic surfaces through a sim-
ple dip-coating approach provides a robust and versatile
surface anchoring technique for tethering antifouling poly-
mers onto various types of surface.
Two polymer grafting strategies have been reported, which
include “graft to” and “graft from” approaches (Fig. 15). The
“graft to” approach consists of direct coating of prefabricated
antifouling polymer end-modified with a catechol moiety or
a short peptide containing Dopa. PEG end-functionalized
with Dopa-containing decapeptide sequence from Mfp-1
[Fig. 15(A)],71 oligopeptide containing 1-3 Dopa residues
[Fig. 15(B)],73,163,263 and a copolypeptide containing Dopa
and lysine residues227 have rendered surfaces resistant to
proteins, cells, and bacteria attachment. Zwitterionic poly-
mers have also demonstrated excellent antifouling capability
due to their ionic hydration.264 Catechol-functionalized
zwitterionic polymers such as poly(carboxybetaine),176
FIGURE 15 Schematic representation of “graft to” and “graft from” approach used to prepare antifouling surfaces. Chemical struc-
tures of catechol-containing anchoring group for immobilizing coatings using the “graft to” coating method (A–C), and three
examples of antifouling polymers (D–F).
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poly(carboxybetaine methacrylate) [Fig. 15(D)],265 and poly
(sulfobetaine methacrylate) (pSBMA)266 have been reported
in the literature.
Peptoid-based antifouling coating has been created with
poly(N-methoxyethylglycine) [Fig. 15(E)], which demonstrat-
ed long-term biofouling-resistant properties.185,267 Similarly,
peptoids containing zwitterionic side chain268 and antimicro-
bial sequences269 have also been used to prepare surfaces
with excellent antifouling and active bactericidal properties,
respectively.
In addition to polymer brushes, ABA triblock copolymers
consisted of catechol-containing “A” blocks and antifouling
“B” block (e.g., PEG, poly(N,N’-dimethylacrylamide)) formed
polymeric loop when coated onto a surface.160,270 These
coatings exhibited enhanced antifouling properties against
protein and cell absorption when compared to polymer
brushes with similar grafting density, due to enhanced steric
hindrance associated with the neutrally charged polymer
loops. Additionally, the coating also exhibited low friction
coefficient, which makes it an ideal candidate as a coating
for ocular lenses.160
The development of various catechol-functionalized initia-
tors (Fig. 10) enabled scientists to prepare coatings
through surface-initiated polymerization (SIP) process or
the so-call “graft-from” approach (Fig. 15). SIP involves
anchoring the catechol–initiator conjugates on to the sur-
face followed by initiating monomer polymerization to cre-
ate a more homogenous and denser polymer brushes when
compared to the “graft to” approach.172 Surface-initiated
ATRP of various antifouling polymer brushes including oli-
go(ethylene glycol) methyl ether methacrylate [Fig.
15(F)],174 zwitterionic pSBMA,177,179 and thermo-
responsive N-isopropylacrylamide271 have been used to
graft polymers onto various substrates ranging from metal
to inert polymers. These coating were highly stable anti-
fouling coatings,174,177,179 with excellent protein-,272 bacte-
rial-,177,179 and cell-resistant175,179 properties. Additionally,
SIP has been used to chemically tether polymers onto col-
loidal and planar substrates as well as grafting polymers
onto nanoparticles.271 When combined with photolithogra-
phy, polymers have been grafted in various micro-scale pat-
terns such as lines and squares.175,271
SUMMARY AND FUTURE OUTLOOK
The incredible moisture-resistant adhesive property of Mfps
has inspired scientists to engineer a wide array of advanced
functional materials. The ability for Dopa to form strong
reversible and irreversible interactions has been used to cre-
ate a unique and versatile platform for developing adhesive
polymers with enhanced material properties (i.e., composite
hydrogels with enhanced mechanical properties, smart mate-
rials and adhesives, and self-healing materials). Additionally,
catechol-functionalized polymers have the potential in func-
tioning as biomedical adhesives, drug carrier for cancer ther-
apy, and antifouling coatings. Although we have focused on
the application of this unique biomimetic technology for bio-
medical applications, catechol-based chemistries have also
been explored in other fields (e.g., drinking water purifica-
tion,272 controlled release of fertilizer,273 nano-composite for
tire rubbers,274 as well as adhesive for battery275 and
plastics135).
Over the last decade or so, scientists have predominantly
focused on incorporating the adhesive catechol moiety into
the design of polymers for interfacial applications. However,
mussel plaque proteins rely on other amino acid residues
(i.e., charged, hydrophobic, and antioxidant thiol residues,
etc.) and intermolecular chemical interactions between mul-
tiple Mfps to create adhesive plaques that bind tightly to the
substrate surface. Additionally, byssus threads utilize strong,
reversible His-metal ion (i.e., zinc, copper) interactions to
minimize permanent structural damage.55 These non-
catechol chemistries are largely neglected in the existing syn-
thetic mimics of these adhesive proteins. The utilization of
these chemistries has only been reported in the last couple
of years (i.e., self-coacervation,4 complex coacervation,103
His-based self-healing hydrogel276). The incorporation of
these designs may yield future adhesive polymers with new
and improved properties.
When designing mussel-mimetic adhesives, there is a need
to modify the design criteria based on the desired applica-
tions. For example, catechol utilizes different interfacial
chemistries to adhere to inorganic and organic substrates.
The reduced catechol is responsible for strong interfacial
binding to inorganic surfaces. As such, incorporating features
that minimize catechol oxidation (i.e., cysteine in Mfp-6,108
hydrophobic residues in Mfp-3s4) can potentially enhance
adhesion to inorganic surfaces in an oxygen-rich and mildly
basic aqueous environment. On the other hand, Dopa needs
to be oxidized to its quinone form in order to participate in
intermolecular covalent crosslinking, which is critical for
designing in situ curable materials and adhesion to biological
substrates.68,78,79 Additionally, reactive oxygen species (i.e.,
H2O2) are released as a byproduct during the oxidation of
catechol.93,95 Given the biological responses to H2O2 is highly
concentration and biological system dependent, the release
of H2O2 from catechol containing adhesive needs to be care-
fully monitored. As such, controlling the redox reaction of
catechol will be critical to the success of these biomimetic
adhesive polymers.
In addition to the various chemical interactions reviewed
here, the byssal thread and plaque also employ gradation in
their materials properties, as well as structural and geomet-
rical designs to minimize structural damage associated with
contact deformation between two dissimilar materials (i.e.,
biological tissue and mineralized surface).12,277,278 To-date,
these features has yet to be incorporated into the develop-
ment of synthetic adhesives. Specifically, an adhesive capable
of bonding two dissimilar surfaces with a large discrepancy
in their materials properties will be highly desirable in many




20 JOURNAL OF POLYMER SCIENCE, PART A: POLYMER CHEMISTRY 2016, 00, 000–000
ACKNOWLEDGMENTS
Authors acknowledge the Office of Naval Research—Young
Investigator Award (N00014-16-1-2463) and the National
Institutes of Health (R15GM104846) for funding.
REFERENCES AND NOTES
1 J. H. Waite, Int. J. Adhes. Adhes. 1987, 7, 9–14.
2 J. Waite, Chem. Ind. 1991, 2, 607–611.
3 E. W. Danner, Y. Kan, M. U. Hammer, J. N. Israelachvili, J. H.
Waite, Biochemistry 2012, 51, 6511–6518.
4 W. Wei, J. Yu, C. Broomell, J. N. Israelachvili, J. H. Waite,
J. Am. Chem. Soc. 2012, 135, 377–383.
5 J. H. Waite, S. O. Andersen, Biochim. Biophys. Acta. 1978,
541, 107–114.
6 L. Ninan, J. Monahan, R. L. Stroshine, J. J. Wilker, R. Shi,
Biomaterials 2003, 24, 4091–4099.
7 L. O. Burzio, V. A. Burzio, T. Silva, L. A. Burzio, J. Pardo,
Curr. Opin. Biotechnol. 1997, 8, 309–312.
8 B. P. Lee, P. B. Messersmith, J. N. Israelachvili, J. H. Waite,
Annu. Rev. Mater. Res. 2011, 41, 99.
9 A. Hagenau, M. H. Suhre, T. R. Scheibel, Prog. Polym. Sci.
2014, 39, 1564–1583.
10 E. Faure, C. Falentin-Daudre, C. Jero^me, J. Lyskawa, D.
Fournier, P. Woisel, C. Detrembleur, Prog. Polym. Sci. 2013, 38,
236–270.
11 J. H. Waite, Ann. NY Acad. Sci. 1999, 875, 301–309.
12 E. Bell, J. Gosline, J. Exp. Biol. 1996, 199, 1005–1017.
13 J. D. Witman, T. H. Suchanek, Mar. Ecol. Prog. Ser. 1984,
16, 259–268.
14 H. Zhao, J. H. Waite, J. Biol. Chem. 2006, 281, 26150–26158.
15 Y. Yao, K. Khoo, M. Chung, S. Li, J. Chromatogr. A 1994,
680, 431–435.
16 D. R. Filpula, S. M. Lee, R. P. Link, S. L. Strausberg, R. L.
Strausberg, Biotechnol. Prog. 1990, 6, 171–177.
17 C. V. Benedict, J. H. Waite, J. Morphol. 1986, 189, 261–270.
18 L. M. Rzepecki, K. M. Hansen, J. H. Waite, Biol. Bull. 1992,
183, 123–137.
19 H. Zhao, J. H. Waite, Biochemistry 2006, 45, 14223–14231.
20 X. Qin, J. H. Waite, J. Exp. Biol. 1995, 198, 633–644.
21 X. X. Qin, J. H. Waite, Proc. Natl. Acad. Sci. USA. 1998, 95,
10517–10522.
22 S. Warner, J. Waite, Marine Biol. 1999, 134, 729–734.
23 V. V. Papov, T. V. Diamond, K. Biemann, J. H. Waite, J. Biol.
Chem. 1995, 270, 20183–20192.
24 H. Zhao, N. B. Robertson, S. A. Jewhurst, J. H. Waite, J.
Biol. Chem. 2006, 281, 11090–11096.
25 R. Y. Floriolli, J. von Langen, J. H. Waite, Marine Biotechnol.
2000, 2, 352–363.
26 J. H. Waite, X. Qin, Biochemistry 2001, 40, 2887–2893.
27 G. Proudfoot, I. Ritchie, Aust. J. Chem. 1983, 36, 885–894.
28 H. G. Silverman, F. F. Roberto, Marine Biotechnol. 2007, 9,
661–681.
29 J. R. Long, J. L. Dindot, H. Zebroski, S. Kiihne, R. H. Clark,
A. A. Campbell, P. S. Stayton, G. P. Drobny, Proc. Natl. Acad.
Sci. USA. 1998, 95, 12083–12087.
30 J. Yu, In Adhesive Interactions of Mussel Foot Proteins;
Springer; 2014, pp 31–41.
31 J. H. Waite, M. L. Tanzer, Science 1981, 212, 1038–1040.
32 J. Schnurrer, C. M. Lehr, Int. J. Pharm. 1996, 141, 251–256.
33 N. D. Catron, H. Lee, P. B. Messersmith, Biointerphases
2006, 1, 134–141.
34 W. M. Chirdon, W. J. O’Brien, R. E. Robertson, J. Biomed.
Mater. Res. Part B: Appl. Biomater. 2003, 66, 532–538.
35 T. L. Coombs, P. J. Keller, Aquatic Toxicol.. 1981, 1, 291–
300.
36 A. M. Baty, P. K. Leavitt, C. A. Siedlecki, B. J. Tyler, P. A.
Suci, R. E. Marchant, G. G. Geesey, Langmuir 1997, 13, 5702–
5710.
37 B. R. Baker, A. N. Laiwalla, J. Y. Yoon, J. Canavate, R. L.
Garrell, Polym. Mater. Sci. Eng. 2001, 85, 115–116.
38 J. P. Gallivan, D. A. Dougherty, J. Am. Chem. Soc. 2000,
122, 870–874.
39 J. P. Gallivan, D. A. Dougherty, J. Am. Chem. Soc. 2000,
122, 870–874.
40 Q. Lu, D. X. Oh, Y. Lee, Y. Jho, D. S. Hwang, H. Zeng,
Angew. Chem. Int. Ed. 2013, 52, 3944–3948.
41 K. V. Pillai, S. Renneckar, Biomacromolecules 2009, 10, 798–
804.
42 S. Das, N. R. M. Rodriguez, W. Wei, J. H. Waite, J. N.
Israelachvili, Adv. Funct. Mater. 2015, 25, 5840–5847.
43 S. Kim, A. Faghihnejad, Y. Lee, Y. Jho, H. Zeng, D. S.
Hwang, J. Mater. Chem. B 2015, 3, 738–743.
44 W. Wei, J. Yu, M. A. Gebbie, Y. Tan, N. R. Martinez
Rodriguez, J. N. Israelachvili, J. H. Waite, Langmuir 2015, 31,
1105–1112.
45 D. S. Hwang, H. Zeng, Q. Lu, J. Israelachvili, J. H. Waite,
Soft Matter 2012, 8, 5640–5648.
46 M. J. Sever, J. J. Wilker, Dalton Trans. 2006, 14, 813–822.
47 C. A. Tyson, A. E. Martell, J. Am. Chem. Soc. 1968, 90,
3379–3386.
48 B. A. Borgias, S. R. Cooper, Y. B. Koh, K. N. Raymond,
Inorg. Chem. 1984, 23, 1009–1016.
49 L. Sommer, Z. Anorg. Allg. Chem. 1963, 321, 191–197.
50 C. Morlay, M. Cromer, Y. Mouginot, O. Vittori, Talanta 1998,
45, 1177–1188.
51 O. K. Borggaard, Acta Chem. Scand. 1972, 26, 393–395.
52 S. W. Taylor, G. W. Luther, III, J. H. Waite, Inorg. Chem.
1994, 33, 5819–5824.
53 S. W. Taylor, D. B. Chase, M. H. Emptage, M. J. Nelson, J.
H. Waite, Inorg. Chem. 1996, 35, 7572–7577.
54 M. J. Harrington, A. Masic, N. Holten-Andersen, J. H. Waite,
P. Fratzl, Science. 2010, 328, 216–220.
55 M. J. Harrington, H. S. Gupta, P. Fratzl, J. H. Waite, J.
Struct. Biol. 2009, 167, 47–54.
56 N. Holten-Andersen, M. J. Harrington, H. Birkedal, B. P. Lee,
P. B. Messersmith, K. Y. C. Lee, J. H. Waite, Proc. Natl. Acad.
Sci. USA. 2011, 108, 2651–2655.
57 N. Holten-Andersen, A. Jaishankar, M. J. Harrington, D. E.
Fullenkamp, G. DiMarco, L. He, G. H. McKinley, P. B.
Messersmith, K. Y. C. Lee, J. Mater. Chem. B 2014, 2, 2467–
2472.
58 M. Krogsgaard, M. A. Behrens, J. S. Pedersen, H. Birkedal,
Biomacromolecules 2013, 14, 297–301.
59 B. J. Kim, H. Cheong, B. H. Hwang, H. J. Cha, Angew.
Chem. 2015, 127, 7426–7430.
60 B. P. Lee, A. Narkar, R. Wilharm, Sens. Actuator. B: Chem.
2016, 227, 248–254.
JOURNAL OF
POLYMER SCIENCE WWW.POLYMERCHEMISTRY.ORG REVIEWS
WWW.MATERIALSVIEWS.COM JOURNAL OF POLYMER SCIENCE, PART A: POLYMER CHEMISTRY 2016, 00, 000–000 21
61 B. P. Lee, M. H. Lin, A. Narkar, S. Konst, R. Wilharm, Sen.
Actuator. B: Chem. 2015, 206, 456–462.
62 B. P. Lee, S. Konst, Adv. Mater. 2014, 26, 3415–3419.
63 B. J. Kim, S. Kim, D. X. Oh, A. Masic, H. J. Cha, D. S.
Hwang, J. Mater. Chem. B. 2015, 3, 112–118.
64 M. Krogsgaard, A. Andersen, H. Birkedal, Chem. Commun.
2014, 50, 13278–13281.
65 R. Kummert, W. Stumm, J. Colloid Interface Sci. 1980, 75,
373–385.
66 B. P. Lee, C. Y. Chao, F. N. Nunalee, E. Motan, K. R. Shull,
P. B. Messersmith, Macromolecules 2006, 39, 1740–1748.
67 M. P. Soriaga, A. T. Hubbard, J. Am. Chem. Soc. 1982, 104,
3937–3945.
68 H. Lee, N. F. Scherer, P. B. Messersmith, Proc. Natl. Acad.
Sci. USA. 2006, 103, 12999–13003.
69 S. A. Mian, X. Gao, S. Nagase, J. Jang, Theor. Chem. Acc.
2011, 130, 333–339.
70 S. A. Mian, L. C. Saha, J. Jang, L. Wang, X. Gao, S. Nagase,
J. Phys. Chem. C 2010, 114, 20793–20800.
71 J. L. Dalsin, B. H. Hu, B. P. Lee, P. B. Messersmith, J. Am.
Chem. Soc. 2003, 125, 4253–4258.
72 J. L. Dalsin, L. Lin, P. B. Messersmith, Polym. Mater. Sci.
Eng. Preprints 2004, 90, 247–248.
73 J. L. Dalsin, L. Lin, S. Tosatti, J. V€or€os, M. Textor, P. B.
Messersmith, Langmuir. 2005, 21, 640–646.
74 J. Yu, W. Wei, M. S. Menyo, A. Masic, J. H. Waite, J. N.
Israelachvili, Biomacromolecules 2013, 14, 1072–1077.
75 L. M. McDowell, L. A. Burzio, J. H. Waite, J. Schaefer, J.
Biol. Chem. 1999, 274, 20293–20295.
76 L. M. Rzepecki, T. Nagafuchi, J. H. Waite, Arch. Biochem.
Biophys. 1991, 285, 17–26.
77 B. P. Lee, J. L. Dalsin, P. B. Messersmith, Biomacromole-
cules 2002, 3, 1038–1047.
78 J. H. Waite, Comp. Biochem. Physiol. Part B: Biochem. Mol.
Biol. 1990, 97, 19–29.
79 M. Sugumaran, H. Dali, V. Semensi, Arch. Insect Biochem.
Physiol. 1989, 11, 127–137.
80 H. Lee, S. M. Dellatore, W. M. Miller, P. B. Messersmith, Sci-
ence 2007, 318, 426–430.
81 C. Cheng, S. Li, S. Nie, W. Zhao, H. Yang, S. Sun, C. Zhao,
Biomacromolecules 2012, 13, 4236–4246.
82 Y. Ren, J. G. Rivera, L. He, H. Kulkarni, D.-K. Lee, P. B.
Messersmith, BMC Biotechnol. 2011, 11, 1–8.
83 K. C. Black, J. Yi, J. G. Rivera, D. C. Zelasko-Leon, P. B.
Messersmith, Nanomedicine 2013, 8, 17–28.
84 C. Lim, J. Huang, S. Kim, H. Lee, H. Zeng, D. S. Hwang,
Angew. Chem. Int. Ed. 2016, 55, 3342–3346.
85 S. M. Kang, N. S. Hwang, J. Yeom, S. Y. Park, P. B.
Messersmith, I. S. Choi, R. Langer, D. G. Anderson, H. Lee,
Adv. Funct. Mater. 2012, 22, 2949–2955.
86 S. Kim, J.-M. Moon, J. S. Choi, W. K. Cho, S. M. Kang, Adv.
Funct. Mater., 2016, 26, 4099–4105.
87 M. M. Cencer, Y. Liu, A. Winter, M. Murley, H. Meng, B. P.
Lee, Biomacromolecules 2014, 15, 2861–2869.
88 J. Li, B. M. Christensen, J. Electroanal. Chem. 1994, 375,
219–231.
89 I. F. Tannock, D. Rotin, Cancer Res. 1989, 49, 4373–4384.
90 H. Ohman, A. Vahlquist, Acta Derm. Venereol. 1994, 74,
375–379.
91 B. R. Soller, R. H. Micheels, J. Coen, B. Parikh, L. Chu, C.
Hsi, J. Clin. Monitor. Comput. 1996, 12, 387–395.
92 B. R. Soller, T. Khan, J. Favreau, C. Hsi, J. C. Puyana, S. O.
Heard, J. Surg. Res. 2003, 114, 195–201.
93 H. Meng, Y. Li, M. Faust, S. Konst, B. P. Lee, Acta Biomater.
2015, 17, 160–169.
94 M. Mochizuki, S. Yamazaki, K. Kano, T. Ikeda, Biochim. Bio-
phys. Acta (BBA) Gen. Subjects 2002, 1569, 35–44.
95 P. Chelikani, I. Fita, P. C. Loewen, CMLS, Cell. Mol. Life Sci.
2004, 61, 192–208.
96 N. Brian, H. Ahswin, N. Smart, Y. Bayon, S. Wohlert, J. A.
Hunt, Eur. Cells Mater. 2012, 24, 249–265.
97 A. M. Cooper, B. H. Segal, A. A. Frank, S. M. Holland, I. M.
Orme, Infect. Immun. 2000, 68, 1231–1234.
98 A. E. K. Loo, Y. T. Wong, R. Ho, M. Wasser, T. Du, W. T. Ng,
B. Halliwell, PLoS One 2012, 7, e49215.
99 S. Chigurupati, M. R. Mughal, E. Okun, S. Das, A. Kumar, M.
McCaffery, S. Seal, M. P. Mattson, Biomaterials 2013, 34, 2194–
2201.
100 N. R. Martinez Rodriguez, S. Das, Y. Kaufman, J. N.
Israelachvili, J. H. Waite, Biofouling 2015, 31, 221–227.
101 R. Stewart, T. Ransom, V. Hlady. J. Polym. Sci. Part B:
Polym. Phys. 2011, 49, 757–771.
102 J. Yu, W. Wei, E. Danner, R. K. Ashley, J. N. Israelachvili,
J. H. Waite, Nat. Chem. Biol. 2011, 7, 588–590.
103 J. H. Ortony, D. S. Hwang, J. M. Franck, J. H. Waite, S.
Han, Biomacromolecules 2013, 14, 1395–1402.
104 M. Yu, J. Hwang, T. J. Deming, J. Am. Chem. Soc. 1999,
121, 5825–5826.
105 J. Yu, W. Wei, E. Danner, J. N. Israelachvili, J. H. Waite,
Adv. Mater. 2011, 23, 2362–2366.
106 G. Springsteen, B. Wang, Tetrahedron 2002, 58, 5291–5300.
107 M. Guvendiren, D. A. Brass, P. B. Messersmith, K. R. Shull,
J. Adhes. 2009, 85, 631–645.
108 S. C. Nicklisch, J. E. Spahn, H. Zhou, C. M. Gruian, J. H.
Waite, Biochemistry 2016, 55, 2022–2030.
109 C. G. De Kruif, F. Weinbreck, R. de Vries, Curr Opin Colloid
Interface Sci. 2004, 9, 340–349.
110 S. Seo, S. Das, P. J. Zalicki, R. Mirshafian, C. D. Eisenbach,
J. N. Israelachvili, J. H. Waite, B. K. Ahn, J. Am. Chem. Soc.
2015, 137, 9214–9217.
111 B. K. Ahn, S. Das, R. Linstadt, Y. Kaufman, N. R. Martinez-
Rodriguez, R. Mirshafian, E. Kesselman, Y. Talmon, B. H.
Lipshutz, J. N. Israelachvili, J. H. Waite, Nat. Commun. 2015, 6,
8663.
112 W. Wei, Y. Tan, N. R. M. Rodriguez, J. Yu, J. N.
Israelachvili, J. H. Waite, Acta Biomater. 2014, 10, 1663–1670.
113 S. Kim, J. Huang, Y. Lee, S. Dutta, H. Y. Yoo, Y. M. Jung,
Y. Jho, H. Zeng, D. S. Hwang, Proc. Natl. Acad. Sci. USA. 2016,
113, E847–E853.
114 R. Moulds, T. Baldwin, Int. J. Adhes. Adhes. 1983, 3, 203–
207.
115 Y. Akdogan, W. Wei, K. Y. Huang, Y. Kageyama, E. W.
Danner, D. R. Miller, N. R. Martinez Rodriguez, J. H. Waite, S.
Han, Angew. Chem. 2014, 126, 11435–11438.
116 W. Wei, L. Petrone, Y. Tan, H. Cai, J. N. Israelachvili, A.
Miserez, J. H. Waite, Adv. Funct. Mater. 2016, 26, 3496–
3507.
117 Q. Lin, D. Gourdon, C. Sun, N. Holten-Andersen, T. H.
Anderson, J. H. Waite, J. N. Israelachvili, Proc. Natl. Acad. Sci.




22 JOURNAL OF POLYMER SCIENCE, PART A: POLYMER CHEMISTRY 2016, 00, 000–000
118 J. Yu, Y. Kan, M. Rapp, E. Danner, W. Wei, S. Das, D. R.
Miller, Y. Chen, J. H. Waite, J. N. Israelachvili, Proc. Natl. Acad.
Sci. USA. 2013, 110, 15680–15685.
119 G. P. Maier, M. V. Rapp, J. H. Waite, J. N. Israelachvili, A.
Butler, Science 2015, 349, 628–632.
120 C. J. Sun, A. Srivastava, J. R. Reifert, J. H. Waite, J. Adhes.
2009, 85, 126–138.
121 M. Cencer, M. Murley, Y. Liu, B. P. Lee, Biomacromolecules
2015, 16, 404–410.
122 X. Ding, G. K. Vegesna, H. Meng, A. Winter, B. P. Lee, Mac-
romol. Chem. Phys. 2015, 216, 1109–1119.
123 E. Amstad, A. U. Gehring, H. Fischer, V. V. Nagaiyanallur,
G. Hahner, M. Textor, E. Reimhult, J. Phys. Chem. C 2011, 115,
683–691.
124 E. Amstad, T. Gillich, I. Bilecka, M. Textor, E. Reimhult,
Nano Lett. 2009, 9, 4042–4048.
125 M. S. Menyo, C. J. Hawker, J. H. Waite, Soft Matter 2013,
9, 10314–10323.
126 J. Anderson, M.-H. Lin, C. Privette, M. Flowers, M. Murley,
B. P. Lee, K. G. Ong, ScienceJet 2015, 4, 1–14.
127 Z. Shafiq, J. Cui, L. Pastor-Perez, V. San Miguel, R. A.
Gropeanu, C. Serrano, A. del Campo, Angew. Chem. Int. Ed.
2012, 51, 4332–4335.
128 L. Garcıa-Fernandez, J. Cui, C. Serrano, Z. Shafiq, R. A.
Gropeanu, V. S. Miguel, J. I. Ramos, M. Wang, G. K.
Auernhammer, S. Ritz, A. A. Golriz, R. Berger, M. Wagner, A.
del Campo, Adv. Mater. 2013, 25, 529–533.
129 H. Ejima, J. J. Richardson, K. Liang, J. P. Best, M. P. van
Koeverden, G. K. Such, J. Cui, F. Caruso, Science 2013, 341,
154–157.
130 J. Guo, H. Sun, K. Alt, B. L. Tardy, J. J. Richardson, T.
Suma, H. Ejima, J. Cui, C. E. Hagemeyer, F. Caruso, Adv.
Healthcare Mater. 2015, 4, 1796–1801.
131 D. G. Barrett, T. S. Sileika, P. B. Messersmith, Chem. Com-
mun. 2014, 50, 7265–7268.
132 G. Shen, R. Xing, N. Zhang, C. Chen, G. Ma, X. Yan, ACS
Nano, 2016, 10, 5720–5729.
133 Z. Liu, B. H. Hu, P. B. Messersmith, Tetrahedron Lett. 2008,
49, 5519–5521.
134 K. C. L. Black, Z. Liu, P. B. Messersmith, Chem. Mater.
2011, 23, 1130–1135.
135 G. Westwood, T. N. Horton, J. J. Wilker, Maclomolecules
2007, 40, 3960–3964.
136 B. H. Hu, P. B. Messersmith, Tetrahedron Lett. 2000, 41,
5795–5798.
137 M. Yu, T. J. Deming, Macromolecules 1998, 31, 4739–4745.
138 B. P. Lee, K. Huang, F. N. Nunalee, K. R. Shull, P. B.
Messersmith, J. Biomater. Sci. Polym. Ed. 2004, 15, 449–464.
139 H. Lee, B. P. Lee, P. B. Messersmith, Nature 2007, 448,
338–341.
140 J. Heo, T. Kang, S. G. Jang, D. S. Hwang, J. M. Spruell, K.
L. Killops, J. H. Waite, C. J. Hawker, J. Am. Chem. Soc. 2012,
134, 20139–20145.
141 H. Nam, M. M. Kim, Food Chem. Toxicol. 2013, 55, 106–
112.
142 S. F. Hamed, Z. Sadek, A. Edris, J. Oleo Sci. 2012, 61, 641–
648.
143 T. F. Bachiega, J. P. B. de Sousa, J. K. Bastos, J. M.
Sforcin, J. Pharm. Pharmacol. 2012, 64, 610–616.
144 A. Almaroof, S. Niazi, L. Rojo, F. Mannocci, S. Deb, Dent.
Mater. 2016, 32, 929–939.
145 A. Almaroof, L. Rojo, F. Mannocci, S. Deb, Dent. Mater.
2016, 32, 149–160.
146 K. Huang, B. P. Lee, D. R. Ingram, P. B. Messersmith, Bio-
macromolecules 2002, 3, 397–406.
147 M. Mehdizadeh, H. Weng, D. Gyawali, L. Tang, J. Yang,
Biomaterials 2012, 33, 7972–7983.
148 C. E. Brubaker, H. Kissler, L. J. Wang, D. B. Kaufman, P. B.
Messersmith, Biomaterials 2010, 31, 420–427.
149 M. Perrini, D. Barrett, N. Ochsenbein-Koelble, R.
Zimmermann, P. Messersmith, M. Ehrbar, J. Mech. Behav.
Biomed. Mater., 2016, 58, 57–64.
150 J. L. Murphy, L. Vollenweider, F. Xu, B. P. Lee, Biomacro-
molecules 2010, 11, 2976–2984.
151 B. Michael, V. Laura, L. M. John, X. Fangmin, L. Arinne, D.
L. William, P. L. Bruce, Biomed. Mater. 2011, 6, 015014.
152 D. G. Barrett, G. G. Bushnell, P. B. Messersmith, Adv.
Healthcare Mater. 2013, 2, 745–755.
153 M. Guvendiren, P. B. Messersmith, K. R. Shull, Biomacro-
molecules 2008, 9, 122–128.
154 P. Sun, J. Wang, X. Yao, Y. Peng, X. Tu, P. Du, Z. Zheng,
X. Wang, ACS Appl. Mater. Interfaces 2014, 6, 12495–12504.
155 J. Y. Park, J. Yeom, J. S. Kim, M. Lee, H. Lee, Y. S. Nam,
Macromol. Biosci. 2013, 13, 1511–1519.
156 K. Kim, J. H. Ryu, D. Y. Lee, H. Lee, Biomater. Sci. 2013, 1,
783–790.
157 A. I. Neto, A. C. Cibr~ao, C. R. Correia, R. R. Carvalho, G. M.
Luz, G. G. Ferrer, G. Botelho, C. Picart, N. M. Alves, J. F. Mano,
Small 2014, 10, 2459–2469.
158 B. P. Lee (Knc Ner Acquisition Sub, Inc.). Patent U.S.
8,030,413, October 4, 2011.
159 C. Lee, J. Shin, J. S. Lee, E. Byun, J. H. Ryu, S. H. Um, D. I.
Kim, H. Lee, S. W. Cho, Biomacromolecules 2013, 14, 2004–
2013.
160 T. Kang, X. Banquy, J. H. Heo, C. N. Lim, N. A. Lynd, P.
Lundberg, D. X. Oh, H. K. Lee, Y. K. Hong, D. S. Hwang, J. H.
Waite, J. N. Israelachvili, C. J. Hawker, Acs Nano 2016, 10, 930–
937.
161 K. M. Mattson, A. A. Latimer, A. J. McGrath, N. A. Lynd, P.
Lundberg, Z. M. Hudson, C. J. Hawker, J. Polym. Sci. Part A:
Polym. Chem. 2015, 53, 2685–2692.
162 J. K. Sprafke, J. M. Spruell, K. M. Mattson, D. Montarnal,
A. J. McGrath, R. P€otzsch, D. Miyajima, J. Hu, A. A. Latimer, B.
I. Voit, J. Polym. Sci. Part A: Polym. Chem. 2015, 53, 319–326.
163 A. Pechey, C. N. Elwood, G. R. Wignall, J. L. Dalsin, B. P.
Lee, M. Vanjecek, I. Welch, R. Ko, H. Razvi, P. A. Cadieux, J.
Urol. 2009, 182, 1628–1636.
164 H. Shao, K. N. Bachus, R. J. Stewart, Macromol. Biosci.
2009, 9, 464–471.
165 C. R. Matos-Perez, J. D. White, J. J. Wilker, J. Am. Chem.
Soc. 2012, 134, 9498–9505.
166 C. L. Jenkins, H. J. Meredith, J. J. Wilker, ACS Appl. Mater.
Interfaces 2013, 5, 5091–5096.
167 C. R. Matos-Perez, J. J. Wilker. Macromolecules 2012, 45,
6634–6639.
168 D. Leibig, A. H. M€uller, H. Frey, Macromolecules 2016, 49,
4792–4801.
169 S. Skelton, M. Bostwick, K. O’Connor, S. Konst, S. Casey,
B. P. Lee, Soft Matter 2013, 9, 3825–3833.
170 T. J. Deming, Nature 1997, 390, 386–389.
171 K. Niederer, C. Sch€ull, D. Leibig, T. Johann, H. Frey, Macro-
molecules 2016, 49, 1655–1665.
JOURNAL OF
POLYMER SCIENCE WWW.POLYMERCHEMISTRY.ORG REVIEWS
WWW.MATERIALSVIEWS.COM JOURNAL OF POLYMER SCIENCE, PART A: POLYMER CHEMISTRY 2016, 00, 000–000 23
172 J. Liu, W. Yang, H. M. Zareie, J. J. Gooding, T. P. Davis,
Macromolecules 2009, 42, 2931–2939.
173 C. Zobrist, J. Sobocinski, J. Lyskawa, D. Fournier, V. Miri,
M. Traisnel, M. Jimenez, P. Woisel, Macromolecules 2011, 44,
5883–5892.
174 X. Fan, L. Lin, P. B. Messersmith, Biomacromolecules 2006,
7, 2443–2448.
175 X. Fan, L. Lin, J. L. Dalsin, P. B. Messersmith, J. Am.
Chem. Soc. 2005, 127, 15843–15847.
176 C. Gao, G. Li, H. Xue, W. Yang, F. Zhang, S. Jiang, Bioma-
terials 2010, 31, 1486–1492.
177 G. Li, G. Cheng, H. Xue, S. Chen, F. Zhang, S. Jiang, Bio-
materials 2008, 29, 4592–4597.
178 Q. Ye, X. Wang, S. Li, F. Zhou, Macromolecules 2010, 43,
5554–5560.
179 J. Kuang, P. B. Messersmith, Langmuir 2012, 28, 7258–7266.
180 M. J. Sever, J. J. Wilker, Tetrahedron 2001, 57, 6139–6146.
181 M. A. Behnam, T. R. Sundermann, C. D. Klein, Org. Lett.
2016, 18, 2016–2019.
182 M. Bodanszky, Principles of Peptide Synthesis; Springer
Science & Business Media: New York, 2012.
183 A. Akemi Ooka, R. L. Garrell, Biopolymers 2000, 57, 92–102.
184 S. M. Miller, R. J. Simon, S. Ng, R. N. Zuckermann, J. M.
Kerr, W. H. Moos, Drug Dev. Res. 1995, 35, 20–32.
185 A. R. Statz, R. J. Meagher, A. E. Barron, P. B. Messersmith,
J. Am. Chem. Soc. 2005, 127, 7972–7973.
186 H. Zeng, D. S. Hwang, J. N. Israelachvili, J. H. Waite, Proc.
Natl. Acad. Sci. USA. 2010, 107, 12850–12853.
187 D. S. Hwang, Y. Gim, H. J. Cha, Biotechnol. Prog. 2005, 21,
965–970.
188 D. S. Hwang, H. J. Yoo, J. H. Jun, W. K. Moon, H. J. Cha,
Appl. Environ Microbiol. 2004, 70, 3352–3359.
189 D. S. Hwang, Y. Gim, H. J. Yoo, H. J. Cha, Biomaterials
2007, 28, 3560–3568.
190 D. S. Hwang, H. Zeng, A. Srivastava, D. V. Krogstad, M.
Tirrell, J. N. Israelachvili, J. H. Waite, Soft Matter 2010, 6,
3232–3236.
191 B. J. Kim, D. X. Oh, S. Kim, J. H. Seo, D. S. Hwang, A.
Masic, D. K. Han, H. J. Cha, Biomacromolecules 2014, 15,
1579–1585.
192 S. Lim, Y. S. Choi, D. G. Kang, Y. H. Song, H. J. Cha, Bio-
materials 2010, 31, 3715–3722.
193 C. Zhong, T. Gurry, A. A. Cheng, J. Downey, Z. Deng, C. M.
Stultz, T. K. Lu, Nat Nano 2014, 9, 858–866.
194 D. S. Hwang, S. B. Sim, H. J. Cha, Biomaterials 2007, 28,
4039–4046.
195 J. J. Wilker, Nat. Chem. Biol. 2011, 7, 579–580.
196 W. Wang, Y. Xu, A. Li, T. Li, M. Liu, R. von Klitzing, C. K.
Ober, A. B. Kayitmazer, L. Li, X. Guo, RSC Adv. 2015, 5, 66871–
66878.
197 D. R. Miller, S. Das, K. Y. Huang, S. Han, J. N. Israelachvili,
J. H. Waite, ACS Biomater. Sci. Eng. 2015, 1, 1121–1128.
198 M. R. Kim, T. G. Park, J. Controlled Release 2002, 80, 69–
77.
199 M. K. Jain, C. A. Grimes, Sens. Actuator. A: Phys. 2002,
100, 63–69.
200 T. Wang, D. Liu, C. Lian, S. Zheng, X. Liu, Z. Tong, Soft
Matter 2012, 8, 774–783.
201 A. K. Gaharwar, S. A. Dammu, J. M. Canter, C. J. Wu, G.
Schmidt, Biomacromolecules 2011, 12, 1641–1650.
202 X. Xiang, F. Long, A. Narkar, R. E. Kinnunen, R.
Shahbazian-Yassar, B. P. Lee, P. A. Heiden, J. Appl. Polym.
Sci., 2016, 133, 1–12.
203 Y. Liu, H. Meng, S. Konst, R. Sarmiento, R. Rajachar, B. P.
Lee, ACS Appl. Mater. Interfaces 2014, 6, 16982–16992.
204 Y. Liu, H. Zhan, S. Skelton, B. P. Lee, MRS Proc. 2013, 1569,
33–38.
205 M. K. Jaiswal, J. R. Xavier, J. K. Carrow, P. Desai, D. Alge,
A. K. Gaharwar, ACS Nano 2015, 10, 246–256.
206 A. GhavamiNejad, C. H. Park, C. S. Kim, Biomacromole-
cules 2016, 17, 1213–1223.
207 Y. Li, H. Meng, Y. Liu, A. Narkar, B. P. Lee, ACS Appl.
Mater. Interfaces 2016, 8, 11980–11989.
208 Y. Li, H. Meng, Y. Liu, B. P. Lee, Sci. World J. 2015, 2015,
685690.
209 M. Djabourov, P. Papon, Polymer 1983, 24, 537–542.
210 W. de Carvalho, M. Djabourov, Rheol. Acta 1997, 36, 591–
609.
211 L. Ionov, Adv. Funct. Mater. 2013, 23, 4555–4570.
212 B. P. Lee, Y. Liu, S. Konst, MRS Proc. 2014, 1710, mrss14-
1710-xx1708-1701.
213 M. Krogsgaard, M. R. Hansen, H. Birkedal, J. Mater. Chem.
B 2014, 2, 8292–8297.
214 S. C. Grindy, R. Learsch, D. Mozhdehi, J. Cheng, D. G.
Barrett, Z. Guan, P. B. Messersmith, N. Holten-Andersen, Nat.
Mater. 2015, 14, 1210–1216.
215 L. He, D. E. Fullenkamp, J. G. Rivera, P. B. Messersmith,
Chem. Commun. 2011, 47, 7497–7499.
216 B. K. Ahn, D. W. Lee, J. N. Israelachvili, J. H. Waite, Nat.
Mater. 2014, 13, 867–872.
217 L. Li, B. Yan, J. Yang, L. Chen, H. Zeng, Adv. Mater. 2015,
27, 1294–1299.
218 C. Heinzmann, S. Coulibaly, A. Roulin, G. L. Fiore, C.
Weder, ACS Appl. Mater. Interfaces 2014, 6, 4713–4719.
219 M. T. Northen, C. Greiner, E. Arzt, K. L. Turner. Adv. Mater.
2008, 20, 3905–3909.
220 X. Luo, K. E. Lauber, P. T. Mather, Polymer 2010, 51, 1169–
1175.
221 M. Banea, L. da Silva, R. Campilho, Ann. Dunarea de Jos
Univ. Galati. Fascicle XII: Weld. Equip. Technol. 2013, 24, 11–
14.
222 G. Sudre, L. Olanier, Y. Tran, D. Hourdet, C. Creton, Soft
Matter 2012, 8, 8184–8193.
223 Y. Z. Wang, L. Li, F. S. Du, Z. C. Li, Polymer 2015, 68, 270–
278.
224 P. Wilke, N. Helfricht, A. Mark, G. Papastavrou, D. Faivre,
H. G. B€orner, J. Am. Chem. Soc. 2014, 136, 12667–12674.
225 P. Wilke, H. G. B€orner, ACS Macro Lett. 2012, 1, 871–875.
226 A. R. Narkar, B. Barker, M. Clisch, J. Jiang, B. P. Lee,
Chem. Mater., 2016, 28, 5432–5439.
227 J. L. Dalsin, D. L. Sherman, B. P. Lee, P. B. Messersmith,
Polym. Mater. Sci. Eng. Preprints 2006, 94, 854–855.
228 M. Mehdizadeh, J. Yang, Macromol. Biosci. 2013, 13, 271–
288.
229 H. T. Peng, P. N. Shek, Expert Rev. Med. Devices 2010, 7,
639–659.
230 R. Fortelny, A. Petter-Puchner, N. Walder, R. Mittermayr,





24 JOURNAL OF POLYMER SCIENCE, PART A: POLYMER CHEMISTRY 2016, 00, 000–000
231 H. Seyednejad, M. Imani, T. Jamieson, A. Seifalian, Br. J.
Surg. 2008, 95, 1197–1225.
232 P. Klimo, Jr., A. Khalil, J. R. Slotkin, E. R. Smith, R. M.
Scott, L. C. Goumnerova, Neurosurgery 2007, 60, 305–309.
233 K. D. Than, C. J. Baird, A. Olivi, Neurosurgery 2008, 63,
ONS182–ONS187.
234 M. S. Allen, D. E. Wood, R. W. Hawkinson, D. H. Harpole,
R. J. McKenna, G. L. Walsh, E. Vallieres, D. L. Miller, F. C.
Nichols, W. R. Smythe, Ann. Thorac. Surg. 2004, 77, 1792–
1801.
235 C. P. Napoleone, A. Valori, G. Crupi, S. Ocello, F. Santoro,
P. Vouhe, N. Weerasena, G. Gargiulo, Interact. Cardiovasc.
Thorac. Surg. 2009, 9, 978–982.
236 G. Bilic, C. Brubaker, P. B. Messersmith, A. S. Mallik, T. M.
Quinn, C. Haller, E. Done, L. Gucciardo, S. M. Zeisberger, R.
Zimmermann, Am. J. Obstet. Gynecol. 2010, 202, 85. e81–85.
e89.
237 C. Haller, W. Buerzle, A. Kivelio, M. Perrini, C. Brubaker, R.
Gubeli, A. Mallik, W. Weber, P. Messersmith, E. Mazza, Acta
Biomater. 2012, 8, 4365–4370.
238 C. Alvarez-Lorenzo, J. Gonzalez-Lopez, M. Fernandez-
Tarrio, I. Sandez-Macho, A. Concheiro, Eur. J. Pharm. Bio-
pharm. 2007, 66, 244–252.
239 Y. Ji, T. Ji, K. Liang, L. Zhu, J. Mater. Sci. Mater. Med.
2016, 27, 1–9.
240 K. A. Burke, D. C. Roberts, D. L. Kaplan, Biomacromole-
cules 2015, 17, 237–245.
241 J. H. Ryu, Y. Lee, W. H. Kong, T. G. Kim, T. G. Park, H. Lee,
Biomacromolecules 2011, 12, 2653–2659.
242 K. Kim, K. Kim, J. H. Ryu, H. Lee, Biomaterials 2015, 52,
161–170.
243 J. Xu, G. M. Soliman, J. Barralet, M. Cerruti, Langmuir
2012, 28, 14010–14017.
244 J. Shin, J. S. Lee, C. Lee, H. J. Park, K. Yang, Y. Jin, J. H.
Ryu, K. S. Hong, S. H. Moon, H. M. Chung, Adv. Funct. Mater.
2015, 25, 3814–3824.
245 S. K. Samal, D. L. Kaplan, E. Chiellini, Macromol. Mater.
Eng. 2013, 298, 1201–1208.
246 T. Yucel, M. L. Lovett, D. L. Kaplan, J. Controlled Release
2014, 190, 381–397.
247 B. Kundu, R. Rajkhowa, S. C. Kundu, X. Wang, Adv. Drug
Deliv. Rev. 2013, 65, 457–470.
248 K. Ghosh, X. Z. Shu, R. Mou, J. Lombardi, G. D. Prestwich,
M. H. Rafailovich, R. A. Clark, Biomacromolecules 2005, 6,
2857–2865.
249 X. Jia, Y. Yeo, R. J. Clifton, T. Jiao, D. S. Kohane, J. B.
Kobler, S. M. Zeitels, R. Langer, Biomacromolecules 2006, 7,
3336–3344.
250 Y. Lee, H. J. Chung, S. Yeo, C. H. Ahn, H. Lee, P. B.
Messersmith, T. G. Park, Soft Matter 2010, 6, 977–983.
251 A. K. Azad, N. Sermsintham, S. Chandrkrachang, W. F.
Stevens, J. Biomed. Mater. Res. Part B Appl. Biomater. 2004,
69, 216–222.
252 S. B. Rao, C. P. Sharma, J. Biomed. Mater. Res. 1997, 34,
21–28.
253 J. Xu, S. Strandman, J. X. Zhu, J. Barralet, M. Cerruti, Bio-
materials 2015, 37, 395–404.
254 N. Harris, M. J. Ford, M. B. Cortie, J. Phys. Chem. B 2006,
110, 10701–10707.
255 K. C. L. Black, T. S. Sileika, J. Yi, R. Zhang, J. G. Rivera, P.
B. Messersmith, Small 2014, 10, 169–178.
256 C. J. Ochs, T. Hong, G. K. Such, J. Cui, A. Postma, F.
Caruso, Chem. Mater. 2011, 23, 3141–3143.
257 J. Cui, Y. Wang, A. Postma, J. Hao, L. Hosta-Rigau, F.
Caruso, Adv. Funct. Mater. 2010, 20, 1625–1631.
258 J. Cui, Y. Yan, G. K. Such, K. Liang, C. J. Ochs, A. Postma,
F. Caruso, Biomacromolecules 2012, 13, 2225–2228.
259 Y. Ju, J. Cui, M. M€ullner, T. Suma, M. Hu, F. Caruso, Bio-
macromolecules, 2015, 16, 807–814.
260 Y. Ju, J. Cui, H. Sun, M. M€ullner, Y. Dai, J. Guo, N.
Bertleff-Zieschang, T. Suma, J. J. Richardson, F. Caruso, Bio-
macromolecules, 2012, 17, 2268–2276.
261 Y. Zhang, M. Huo, J. Zhou, D. Yu, Y. Wu, Carbohydr.
Polym. 2009, 77, 231–238.
262 V. B. Damodaran, N. S. Murthy, Biomater. Res. 2016, 20, 1–
11.
263 R. Ko, P. A. Cadieux, J. L. Dalsin, B. P. Lee, C. N. Elwood,
H. Razvi, J. Endourol. 2008, 22, 1153–1160.
264 S. Jiang, Z. Cao, Adv. Mater. 2010, 22, 920–932.
265 N. D. Brault, C. Gao, H. Xue, M. Piliarik, J. Homola, S.
Jiang, Q. Yu, Biosens. Bioelectron. 2010, 25, 2276–2282.
266 W. Yang, H. S. Sundaram, J.-R. Ella, N. He, S. Jiang, Acta
Biomater., 2010, 40, 92–99.
267 A. R. Statz, A. E. Barron, P. B. Messersmith, Soft Matter
2008, 4, 131–139.
268 K. H. A. Lau, T. S. Sileika, S. H. Park, A. M. L. Sousa, P.
Burch, I. Szleifer, P. B. Messersmith, Adv. Mater. Interfaces
2015, 2, 1400225.
269 A. R. Statz, J. P. Park, N. P. Chongsiriwatana, A. E. Barron,
P. B. Messersmith, Biofouling 2008, 24, 439–448.
270 L. Li, B. Yan, L. Zhang, Y. Tian, H. Zeng, Chem. Commun.
2015, 51, 15780–15783.
271 X. Wang, Q. Ye, T. Gao, J. Liu, F. Zhou, Langmuir 2012, 28,
2574–2581.
272 M. Lee, J. Rho, D. E. Lee, S. Hong, S. J. Choi, P. B.
Messersmith, H. Lee, ChemPlusChem 2012, 77, 987–990.
273 X. Jia, Z. Y. Ma, G. X. Zhang, J. M. Hu, Z. Y. Liu, H. Y.
Wang, F. Zhou, J. Agric. Food Chem. 2013, 61, 2919–
2924.
274 X. D. Pan, Z. Qina, Y. Y. Yana, P. Sadhukhana, Polymer
2010, 51, 3453–3461.
275 M. H. Ryou, J. Kim, I. Lee, S. Kim, Y. K. Jeong, S. Hong, J.
H. Ryu, T. S. Kim, J. K. Park, H. Lee. J. W. Choi, Adv. Mater.
2013, 25, 1570–1570.
276 D. E. Fullenkamp, L. He, D. G. Barrett, W. R. Burghardt, P.
B. Messersmith, Macromolecules 2013, 46, 1167–1174.
277 A. Tamarin, P. Lewis, J. Askey, J. Morphol. 1976, 149, 199–
221.
278 K. W. Desmond, N. A. Zacchia, J. H. Waite, M. T. Valentine,
Soft Matter 2015, 11, 6832–6839.
JOURNAL OF
POLYMER SCIENCE WWW.POLYMERCHEMISTRY.ORG REVIEWS
WWW.MATERIALSVIEWS.COM JOURNAL OF POLYMER SCIENCE, PART A: POLYMER CHEMISTRY 2016, 00, 000–000 25
